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The introduction of clusters of multi-core and many-core processors has played
a major role in recent advances in tackling a wide range of new challenging applica-
tions and in enabling new frontiers in BigData. However, as the computing power
increases, the programming complexity to take optimal advantage of the machine’s
resources has significantly increased. High-performance computing (HPC) tech-
niques are crucial in realizing the full potential of parallel computing. This research
is an interdisciplinary effort focusing on two major directions. The first involves
the introduction of HPC techniques to substantially improve the performance of
complex biological agent-based models (ABM) simulations, more specifically sim-
ulations that are related to the inflammatory and healing responses of vocal folds
at the physiological scale in mammals. The second direction involves improvements
and extensions of the existing state-of-the-art vocal fold repair models. These im-
provements and extensions include comprehensive visualization of large data sets
generated by the model and a significant increase in user-simulation interactivity.
We developed a highly-interactive remote simulation and visualization frame-
work for vocal fold (VF) agent-based modeling (ABM). The 3D VF ABM was ver-
ified through comparisons with empirical vocal fold data. Representative trends of
biomarker predictions in surgically injured vocal folds were observed. The physio-
logically representative human VF ABM consisted of more than 15 million mobile
biological cells. The model maintained and generated 1.7 billion signaling and ex-
tracellular matrix (ECM) protein data points in each iteration. The VF ABM
employed HPC techniques to optimize its performance by concurrently utilizing the
power of multi-core CPU and multiple GPUs. The optimization techniques included
the minimization of data transfer between the CPU host and the rendering GPU.
These transfer minimization techniques also reduced transfers between peer GPUs
in multi-GPU setups. The data transfer minimization techniques were executed
with a scheduling scheme that aims to achieve load balancing, maximum overlap of
computation and communication, and a high degree of interactivity. This scheduling
scheme achieved optimal interactivity by hyper-tasking the available GPUs (GHT).
In comparison to the original serial implementation on a popular ABM framework,
NetLogo, these schemes have shown substantial performance improvements of 400x
and 800x for the 2D and 3D model, respectively. Furthermore, the combination
of data footprint and data transfer reduction techniques with GHT achieved high-
interactivity visualization with an average framerate of 42.8 fps. This performance
enabled the users to perform real-time data exploration on large simulated outputs
and steer the course of their simulation as needed.
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In recent decades, the world of computational science has experienced a phe-
nomenal progress. Driven by an unprecedented computing power and the ever-
increasing human thirst for knowledge, the complexity of scientific simulations and
computations has increased substantially. At the end of Dennard scaling, which
assumes constant power density as transistors get smaller [2], a prominent way to
keep up with the performance demand has shifted towards multi-core and many-core
computing architectures. As opposed to the automatic performance gain through
higher clock frequencies achieved before the Dennard scaling ended, the performance
gain in the post-Dennard era has been achieved through parallel execution. This
change has placed a significant responsibility for performance improvement on the
programmers. Well designed parallel programs are essential in leveraging the avail-
able resources on parallel architectures. There are libraries and language extensions
such as OpenMP [3] and OpenACC [4] available to make parallel programming eas-
ier. However, the simplicity through high level abstractions comes at the expense
of a decrease in control the programmer has over her program. In many cases, less
control is not a problem as long as an acceptable speedup is achieved. Nonetheless,
in other cases, the programmer may need the best possible performance to achieve
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her goal. In these cases, different aspects of high-performance computing (HPC) de-
signs such as appropriate parallelization, programming models, available resources,
scheduling and data distribution need to be considered.
The popularity of Graphics Processing Units (GPUs) has been rising in the
scientific computing community. The computing power of massive data-parallelism
offered by GPU has been utilized by researchers to enhance the performance of
data-intensive applications across different fields [5, 6]. For example, in machine
learning and data mining, accelerations through single-GPU and multi-GPU sys-
tems have resulted in order of magnitudes of performance improvement over CPU
implementations [7]. However, as the data size grows, one limiting factor that in-
terferes with scalability of GPU algorithms is its memory capacity. Fortunately,
GPU devices are not stand-alone and they need a CPU host to operate. Hence,
the relationship between the host and its accelerators is not mutually exclusive, but
rather complementary if utilized appropriately. Though the speed of CPU-GPU
interconnect (PICe) is usually the main bottleneck, a carefully designed heteroge-
neous computing algorithm can mitigate this overhead and offers joint advantages
from both architectures through alleviation of individual limitations. For example,
communication-computation overlap has often been used to mask the CPU-GPU
data transfer latency [8–10] in attempts to achieve optimal throughput.
Computational medicine is one of the areas that has been yielding tremendous
benefits from the HPC advancements [11]. High-fidelity models are usually both
computationally- and data-intensive. The adoption of HPC in the computational
biology community has given rise to many complex models at scales not possible
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through traditional sequential algorithms. As computer models are becoming the
cost-effective method of choice for developing, testing, validating, and instigating
new findings and theories, HPC has become the method of choice in accelerating
these models. Despite the number of HPC developments in computational medicine,
there is very little work attempting to fully utilize both CPU and GPUs simultane-
ously. This gap leaves a window of opportunity for designing efficient heterogeneous
computing algorithms for large-scale biological physiological system simulations.
This dissertation focuses on tackling the complexity of biological simulations
through the development of HPC techniques that take full advantage of the power of
heterogeneous CPU-GPU(s) platforms. More specifically, this work targets the mod-
eling of inflammation and repair process of vocal folds (VF) using an agent-based
modeling (ABM) approach. The ABM approach was used due to its bottom-up
structure that makes cell modeling and incremental knowledge aggregation relatively
simple [12]. The inflammation and repair process is multi-scale in nature, involving
cellular-level and molecular-level operations and interactions [13]. Biological cells
were modeled using autonomous agents. These cells communicate via chemical sig-
naling and perform cellular-level processes such as migration, chemical secretion,
and tissue healing in a spatially-discretized environment. The developed HPC tech-
niques were designed in a top-down approach starting from task scheduling, task
execution down to data movements. The rest of this chapter briefly discusses the
major contributions of this work and outlines the organization of this dissertation.
Contributions This dissertation describes a set of novel HPC algorithms to
optimize the execution of complex biological simulations at task-scheduling level,
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task-execution level, down to host-device data movement level on heterogeneous
CPU-GPU(s) computing platforms.
At the task-scheduling level, three original task-device mapping strategies were
developed. First, a simple strategy was designed to enhance hardware resource uti-
lization of 2D VF ABMs by overlapping CPU and GPU numerical simulation tasks.
The scheduling strategy was then extended to further overlap visualization tasks,
as the visualization tasks became noticeably time consuming in the much larger
3D models. Finally, task-scheduling strategy for large 3D models was restructured
to accommodate GPU hyper-tasking (GHT). The ability to hyper-task the GPUs
increased the visualization interactivity by allowing the non-rendering GPUs to par-
ticipate in the visualization process of their local data and minimize the amount of
off-device data transfers.
At the task-execution level, OpenMP and custom thread-safe concurrent data
structure were used to speed up the cellular-level processes. Chemical diffusion com-
putations were then optimized using convolution-based diffusion to advance multiple
iterations of chemical diffusion in a single step of computation. Furthermore, the
performance of the visualization component was enhanced through data access re-
duction techniques including adaptive sampling and activity-aware host-device data
transfers.
The coupling of task-scheduling and task-execution level HPC techniques for
2D VF ABM resulted a significant speedup of 35x and 7x over sequential and
OpenMP versions, respectively. The 3D VF ABM achieved 2.4x the throughput
of 2D VF ABM. More specifically, the 3D VF ABM was capable of simulating 17
4
million biological cells in under 7 seconds per iteration, and visualizing time-varying
volumetric output of 1.7 billion protein data points with an average framerate of
42.8 fps. This performance improvement results in real-time interactivity that al-
lows users to explore large simulated data sets on a remote server without any lag.
Our simulation platform also offers computational steering capability as the visu-
alization is performed in situ. The ability to simulate, explore data and perform
computational steering in real-time can assist modelers and researchers significantly
in testing and validating their hypotheses and new scientific discoveries.
Dissertation Organization This dissertation consists of 7 chapters. The
next chapter (Chapter 2) provides a background and overview of the fields sur-
rounding this work including HPC, systems biology simulation and 3D visualization
of biological systems. Chapter 3 - 5 discuss the details of HPC techniques used in
this work, which were adapted from our previous publications [14–17]. More specif-
ically, Chapter 3 discusses the techniques used to achieve optimal concurrency at
the scheduling level. The chapter begins with the explanation of the task catego-
rization method which became the basis of heterogeneous platform task mapping
strategies used in this work. The chapter then expands on three different task-device
mapping strategies. Chapter 4 discusses the numerical simulation optimizations for
both cellular- and molecular-level processes. First, parallelization of cellular level
processes using OpenMP on CPU is discussed, followed by a discussion on rationale,
implementation and optimization of convolution-based diffusion using fast Fourier
transform (FFT).
Chapter 5 describes the optimization techniques developed to enhance the
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visualization performance and interactivity. First, the importance of in situ visual-
ization and the protocol used in the work is discussed. The chapter then establishes
data access pattern types, which were essential in further development of host-device
data transfer minimization using an activity-aware redundancy reduction scheme.
Finally, a heuristic for choosing best parameter (block size) for this Host-Device
Activity Aware Data Copy (HADC) is proposed.
Chapter 6 starts with model configuration details to give an overview of the
simulation scale. The chapter then details the performance gain achieved in 2D,
3D and high-interactivity 3D models, through different HPC techniques developed.
Since different forms of sampling were used to reduce GPU memory requirements,
the trade-offs between accuracy and performance were studied. The performance
gain using parameter recommendation heuristic for the HADC technique was mea-
sured and compared against the best parameter. Lastly, the details regarding model
verification are discussed.
Chapter 7 provides conclusion and discusses future directions of this work.
Thesis Statement The product of this dissertation is a set of heterogeneous
computing algorithms applicable to discrete-time multi-scale models of complex
cellular-level systems. Designed to run efficiently on CPU-GPU(s) heterogeneous
computing platforms, these techniques can be applied to cellular-level models to
significantly improve the performance of both numerical simulation and visualiza-
tion through efficient task scheduling, task execution and host-device data manage-
ment. Demonstrated through the case study of vocal fold repair model, the HPC
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methods developed in this dissertation enable real-time simulation and in situ visu-
alization of large-scale complex biological systems, offering computational steering
and highly interactive time-varying volumetric data exploration capability at the
scale not currently present in other related work. The computational steering and
real-time data exploration capabilities allow biomedical researchers to implement,
test and refine their cellular-level models. This ability to perform iterative model




To provide an overview of the fields surrounding this dissertation, this chapter
begins with a brief discussion of the main HPC hardware and software paradigms.
The chapter then provides the details of the simulation approach used, followed
by the background on the specific case study of vocal fold inflammation. Existing
work in the fields of biological system modeling, HPC ABM in bio-applications and
visualization in Bio-ABMs will be discussed briefly. Finally, the chapter ends with
a description of the hardware and software environment employed in this work.
2.1 Parallel Computing Architectures
In this section, some of the relevant trends in computing hardware will be
discussed. First, a brief background on evolution of popular processors such as
microprocessor (CPUs) and coprocessor/accelerator (GPUs) will be provided. Next,
we discuss the trends of both computing clusters and personal computers. The
main focus of this discussion will be on accelerators as x86 seems to have been
the dominant microprocessor architecture for many years [18], thus no substantial
changes have occurred in terms of microprocessors. Specifically, we will use GPU as
the representative coprocessor architecture because it is the most common type of
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accelerators [18].
2.1.1 Multi-Core Central Processing Units (CPUs)
Driven by a performance hungry market, there is always a demand for faster
processors regardless of the speed of the fastest available processor at the time.
Moore’s law predicts that the number of transistors in a chip doubles every 18
months [19]. And continuous performance improvement of a processor has been
relying on the increase in density of integrated circuits (ICs) on a chip for decades [20,
21]. However, according to Pollack’s rule, performance increase by microarchitecture
alone is roughly proportional to square root of increase in complexity [22], thus the
performance of a single processor core does not scale linearly with the number of logic
on the core. As the transistor size shrinks, the leakage current becomes larger [23].
And with higher integrated density, power dissipation becomes the bottleneck of
the architecture [22, 23]. Alternatively, performance boost could be achieved by
increasing the clock speed, or the frequency at which the processor operates at.
This gives more instructions per second; however, due to increased dynamic power
dissipation and design complexity, the clock frequency is currently limited to about
4 GHz [24]. Multi-core architecture allows for a scalable processor design and offers
a way to achieve better performance without infringing on the power dissipation
requirements [22–24].
Today, a server-grade CPU chip can consist of up to 56 CPU cores [25]. A
powerful compute node may consist of multiple CPU sockets resulting in more cores.
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For more computing power, multiple compute nodes can work together in a cluster
and communicate among themselves via high-speed interconnection networks.
2.1.2 Graphics Processing Units (GPUs)
GPUs were originally designed as special purpose processors focusing on graph-
ics computations such as polygon calculations, or image filtering. Since the introduc-
tion of the CUDA high level programming environment by NVIDIA, GPUs have be-
come the preferred high performance computing platform especially for data parallel
computations, achieving a much better performance/energy tradeoff than multicore
CPUs. In general, a GPU consists of thousands of processing cores, making them
very suitable for data parallel operations. The scientific community has picked up
interest in GPU computing due to their computationally demanding applications,
which has given rise to General Purpose GPU (GPGPU). CUDA was then intro-
duced in 2007 to enable GPGPU programming in C with C-like extensions (for more
details please refer to Section 2.6). Since its introduction, more than 100 million
computers with CUDA-capable GPUs have been shipped to end users [26].
GPUs consist of a number of Streaming Multiprocessors (SMs), each of which
contains a number of processor cores (e.g. stream processors or CUDA cores). Each
SM consists of tens of thousands of registers used by GPU threads during kernel
executions. The SMs also contain different levels of caches including L1 caches,
texture caches, constant caches and shared memory [27]. A GPU typically contain
thousands of cores making GPUs capable of launching thousands of threads simul-
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taneously. All the SMs have access to the high bandwidth Device memory (peak
bandwidth 240 GB/s). The best bandwidth is achieved through data coalescing.
Coalesced memory access refers to a scenario where number of memory transactions
is minimized when consecutive threads access consecutive memory locations.
Graphics processing hardware has existed since the 1990’s [28], long before
the term GPU was even devised by NVIDIA in 1999 with the launch of its GeForce
256, a graphics accelerator hardware with 23 million transistors [29]. The dedicated
graphic cards offered new graphics features and huge performance improvements,
resulting in tremendous interests from the gaming community [30]. Since then,
more and more personal computers picked up on the host-accelerator architectures
for their immense graphics capability. The prices of these units also play a role in
their popularity as decent GPUs are becoming more affordable [31]. Today, one of
the most popular graphics card, NVIDIA GeForce GTX 1060 [32], with 4.4 billion
transistors on 1280 cores, costs less than $300 [33]. As the demand for graphics
complexity increases with the performance per dollar, dedicated GPU hardware is
present in most personal machines used by gamers, film editors and anyone serious
about utilizing computer graphics capability and performance.
2.1.3 Heterogeneous Computing
Heterogeneous computing systems refer to a diverse set of computing resources
interconnected via high speed network to collaboratively support execution of com-
putationally intensive parallel and distributed applications [34]. Heterogeneous plat-
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forms of various architectures and scales have become increasingly popular in both
HPC and personal computing platforms. For example the larger scale platforms
are based on large clusters of different types of multicore CPUs and many-core ac-
celerators such as Graphics Processing Units (GPUs) [35–37], Field-Programmable
Gate Arrays (FPGAs) [35, 38], while FPGA and Digital Signal Processors (DSPs)
are often seen in power critical systems [39, 40]. In fact, almost all current per-
sonal computers are based on heterogeneous computing platforms that include a
multicore CPU with an attached accelerator of one or more GPUs. However, most
often the applications do not make effective use of these available resources. For
example, if the CPU is only there to move data and launch GPU kernels, or the
GPU is there to merely act as an accelerator to the CPUs, the program is not
really employing the full power of the heterogeneous computing environment. On
the other hand, if both CPUs and GPUs collaborate to handle important computa-
tions, then major performance gains are possible. However, this requires a careful
scheduling and orchestration of the operations using the available resources. For
example, to mask the CPU-GPU data transfer latency in out-of-core GPU memory
management for MapReduce-based large-scale graph processing, researchers have
proposed a technique to overlap computations and data-transfers [8]. In addition to
computation-communication overlap, another heterogeneous computing larger-scale
graph processing framework, HyGraph [10], achieved performance improvements
over its cpu-only and gpu-only counterpart through dynamic scheduling. A major
part of this dissertation focuses on optimal collaboration of a multi-core CPU with
one or more GPUs on a single compute node. This increases the applicability of
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the contributions of this work to other applications, as CPUs-GPUs platforms are
pervasive today.
2.1.4 Computing Clusters
A computing cluster is a network of computers that work together to form a
single high-performance distributed system. These computers are usually connected
via fast local connections such as Infiniband™ and Gigabit Ethernet interconnects.
As microprocessors get cheaper and network interconnects become faster, computing
clusters offer a solution to computationally intensive applications by scaling out
commodity machines. There is a wide spectrum of computing clusters ranging from
small business clusters to large supercomputers.
Accelerators are becoming more and more popular in squeezing the teraflops-
per-second into supercomputing systems. In 2010, there were only 10 GPU-based
systems in the top 500 list. Despite the fluctuation, the overall trend has been
favorable towards accelerators from different architecture families. For example, in
2012, NVIDIA GPUs alone account for 50 systems in the list, and that number has
gone up to 64, 85 and 128 in 2015, 2017 and 2018 [41], respectively. As of November
2017, out of the top 50 HPC applications, more than two-third offer support for
GPU-based acceleration with more under development to offer this feature [42].
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2.2 Parallel Programming Models
Parallel programming models are built on top of parallel hardware and phys-
ical memory architectures. Theoretically, any type of parallel programming model
can be implemented irrespective to the underlying hardware architecture, though
efficiency may decrease if the programming model and underlying hardware are not
somewhat compatible. As in parallel computing architectures, there are also multi-
ple ways to classify parallel programming models. This section will focus on the two
widely used parallel programming communication models (shared and distributed
memory), data-parallel model (SPMD), hybrid models and the rapidly emerging
model, MapReduce.
Shared Memory Parallel Programming (SMP) — Shared Address Space
Model. When memory is global and all threads have the same view of memory, we
are in a shared address space. This programming model makes it easy for thread to
communicate and modify the states of the global memory. However, if synchroniza-
tion is not implemented correctly, the program will not execute correctly. Incorrect
synchronization can cause problems such as data-races and dead-locks. Examples
of shared memory APIs include POSIX-thread (pthread) [43] and Open Multipro-
cessing (OpenMP) [3].
Distributed Memory Parallel Programming — Message Passing Model.
In distributed memory model, each process has their own memory space which is
not directly accessible or visible to other processes. Thus, message passing commu-
nication model is used in this type of memory model for processes to communicate
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with each other and requesting state changes in others’ memory spaces. This type of
memory is mostly present in computing clusters, as multiple commodity hardware
are connected to each other via interconnects. The Message Passing Interface (MPI)
forum was formed in 1992 and released the first part of MPI specification in 1994,
with the following parts in 1996 and 2012, respectively [44–47]. MPI implementa-
tions exist for most, if not all, modern parallel computing systems, however, some
of the implementations may not support all functionality specified by MPI-1, MPI-2
and MPI-3.
Data Parallel Programming Model (SPMD) — In this model, the pro-
gram performs the same operations on different parts of a data set. Historically,
data parallel programming model were mostly used to perform the same instruc-
tions to each array element such as computations seen in vector processors [48, 49].
For example, add(A, B, n) computes, in parallel, an addition of each of the n ele-
ments of vector (array) A to the corresponding element in vector B. In modern days,
data parallelism is mostly seen in the Single Program Multiple Data programming
model. An example includes GPU computing, which uses the same program to pro-
cess multiple data elements concurrently [50]. More examples include partitioned
global address space (PGAS) languages such as Unified Parallel C (UPC), X10 and
Chapel [51]. PGAS assumes a global memory view that is partitioned [52]. Each
partition of the global memory belongs to a program thread. In PGAS, all threads
execute the same program which operates on each thread’s own memory partition.
Hybrid Memory Parallel Programming — This model combines more
than one of the previously mentioned parallel programming models together. For
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example, on a cluster of multi-core compute nodes, distributed and shared memory
programming can be combined by allowing threads to view and modify their local
memory with OpenMP and communicate with processes from other compute nodes
via MPI. Another example would be using pthread to parallelize the execution of
certain compute tasks in a shared-memory manner on a multi-core CPU and offload
computationally intensive compute tasks to a GPU. The hybrid model allows the
programmer to strive for ”the best of both worlds” model of parallel programming,
given their specific application needs.
MapReduce — Developed and originally used by Google, MapReduce has
continuously been gaining traction from the big data community since its first pub-
lication in 2008 [53]. Since then, MapReduce has been featured as the parallel
programming model of choice to enhance the performance of many big data appli-
cations in fields including machine learning, data mining and bioinformatics [54–57].
MapReduce takes in a set of input < key, value > pairs, and produces a set
of output < key, value > pairs. The programmer expresses their computations in
MapReduce by writing two functions: map and reduce. The map function writ-
ten by the programmer produces a set of intermediate < key, value > pairs. The
underlying framework shuffles these intermediate pairs, group them by their inter-
mediate keys, and pass them to the reducer. To process large amounts of data in
a distributed fashion, the underlying distributed file system (DFS) was designed to
handle machine failure and offer fault tolerance through redundant execution and
data replications. In 2011, Apache Software Foundation released its first version of
fault tolerance DFS, Apache Hadoop. As opposed to the Google File System (GFS),
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Hadoop is open-source, thus allowing more access to the MapReduce programming
model.
Despite its applicability to certain big data applications, MapReduce is not
suitable for iterative algorithms as all inputs and outputs of the compute stages
require disk access. This has put limitations on the performance enhancement of
multiple applications requiring iterative data accesses including training algorithms
for machine learning models. This limitation of MapReduce has motivated the
development of Apache Spark [58]. Since its released in 2014, Spark has been gaining
significant interest from the big data and machine learning community as it mitigates
the limitations of MapReduce by allowing in-memory processing, thus alleviating
I/O overhead [59].
2.3 Agent-Based Modeling (ABM)
Agent-based modeling is a widely adopted approach to quantitatively simulate
dynamical systems [60]. The popularity of ABMs can be observed in the variety of
ABM frameworks developed in the past decade (for reviews, please see [60–63]). This
modeling approach abstracts the system of interest by using a set of autonomous
objects, or ABM agents, to execute the decision-making behavior of individual com-
ponents of the system. These ABM agents interact among themselves, as well as
with their environment according to a number of predefined stochastic and/or de-
terministic rules [60, 62]. In contrast to equation-based approaches, ABMs are de-
centralized. That is, the system’s behavior is determined by the collective behavior
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of each individual agent in the system. Although a universal definition of ABMs
remains debatable [60], fundamental components of ABM typically include: agent
set, agent relationship set, and agents’ environment [12].
Firstly, a set of agents includes the agents themselves, their attributes and
their behavioral rules. Agents’ behavioral rules govern their decisions and ac-
tions. In ABM, agents can represent a wide spectrum of individual entities such
as consumers, markets and geographic regions in economic models [64–69], animals
in ecosystems [70–73] and biological cells and proteins in systems biology mod-
els [1, 14, 74–83]. Secondly, the set of “agent relationships and methods of interac-
tions” [12] defines the criteria of a group of entities each agent is bound to interact
with, and how these interactions are carried out. For instance, some ABMs may
allow agents to interact only directly with other agents, some may allow only in-
direct interactions while some may allow both [84]. A direct interaction represents
an immediate impact one agent leaves on another. Particle collision is an exam-
ple of a direct interaction, where colliding particle agents affect the states of each
other directly. On the other hand, indirect interactions have been used to mimic
the lingering effects of transmitted signals [85–88]. An example of indirect agent
interaction includes chemical secretion as a form of inter-cellular communication.
This chemical secretion example is classified as indirect because the agents alter the
states of the environment to communicate, rather than altering the states of the
recipient agents directly. Lastly, the agents’ environment houses the autonomous
agents. This space can be discrete lattice-based [89], continuous lattice-free [90]
or hybrid [91]. The environment may maintain local attributes depending on the
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application and underlying implementation [92].
Our collaborators’ first published ABM [74] was programmed on the platform
of Netlogo and thus most of the terminology used herein was adopted from the dic-
tionary of NetLogo [93]. In both 2D and 3D implementations described in this work,
the simulation environment, also known as the ABM world, represents human tissue.
The environment is spatially discretized into rectangular volumes called patches.
Each mobile agent represents an inflammatory cell that can move from one patch
to an adjacent patch and make decisions to perform certain actions at discrete time
steps. Agents make decisions based on the state of the patches, which allow them
to alter their environment to interact indirectly with other agents. Chemokines and
extracellular matrix (ECM) proteins are associated with the states of the patches.
2.4 Vocal Folds Injury Model
2.4.1 Problem Background
Voice problems were estimated to affect one in 13 adults in the United States
annually [94]. In one study, nearly one third of the sampled population has expe-
rienced voice disorder symptoms at some point in their lifetime [95]. In particular,
voice disorders constitute a major occupational hazard in many professions such as
salespeople, teachers, performing artists, attorneys, and sport coaches, due to the in-
tensive vocal demand of the job [96–100]. The estimated lifetime prevalence of voice
disorders is as much as 80% in occupational voice users [101–103]. Human vocal
folds are under continuous biomechanical stress during voice production. Exces-
19
sive phonatory stress can induce a cell-mediated inflammatory response and struc-
tural tissue damage, leading to a pathological condition [104–109]. Patients with
phonotraumatic lesions are usually prescribed behavioral voice therapy [105, 110]
or surgical excision of the lesion in combination with various adjunctive treatments
[111–117]. Unfortunately, the healing outcome of voice treatments often depend
on the lesion, the treatment dose, and the patient’s vocal needs [74, 118–121]. The
success rate of voice treatment varies extensively between 30% and 100% [122–127] ,
making the treatment planning process difficult for voice therapists and surgeons.
The unpredictable treatment outcome is axiomatic and takes a huge toll on a per-
son’s career, a clinician’s decision-making process and society’s healthcare costs. A
predictive tool that can estimate voice treatment success would spare patients from
unnecessary and costly treatments and potentially harmful side effects.
A series of agent-based models (ABM) have been developed to numerically sim-
ulate the essential biology underlying vocal injury and repair that may help clinicians
to better tailor treatments for patients with voice disorders [1, 14, 74, 77, 128–130].
The flow diagram (modified from [74]) of the interactions between all the compo-
nents in the model is shown in Fig 2.1. We first developed 2D vocal fold ABM [14]
to simulate inflammation and repair of a single vocal fold tissue slab. The 2D
vocal fold ABM was then upgraded to a much larger 3D model to resemble the
physiological dimension of human vocal folds. Techniques including diffusion kernel
reduction and data copy minimization were used to boost the performance of both
the computation and visualization executions. These techniques were coupled with
a scheduling scheme that completely masks the execution time of the computation-
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Figure 2.1: Flowchart of vocal fold inflammation and healing events in ABM. This
diagram is taken from [74].
ally demanding diffusion and visualization tasks on heterogeneous compute nodes
consisting of multi-core CPU and multiple GPUs. This low-cost, high-resolution
and high-performance computing ABM platform with real-time visualization capa-
bility is original in disease modeling and necessary to make complex disease models
executable and practical in clinical settings.
A vocal fold (VF) ABM simulating inflammation and repair was developed and
partially verified against empirical vocal fold trauma data [1, 74, 77]. Inflammatory
cells were implemented as ABM agents, while chemokines and extra-cellular matrix
(ECM) proteins were implemented as states of the ABM patches. The aggregation
of these ABM components yields the state of the vocal fold (ABM world) at each
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given point in simulated time. Table 2.1 summarizes the roles that each type of cell
agents plays in the healing process. At the time of acute injury, the traumatized
mucosal tissue within the damaged area triggers platelet degranulation [1, 77]. Dif-
ferent chemokines get secreted resulting in vasodilation stimulation and attraction
of inflammatory cells, namely, neutrophils and macrophages to the wound site. Ac-
tivated neutrophils and macrophages at the wound area further secrete chemokines
to attract fibroblasts and clean up cell debris. To repair the wound, activated fibrob-
lasts proliferate and deposit extracellular matrix (ECM) proteins such as collagen,
elastin, and hyaluronan. These ECM proteins then form a scaffold for support-
ing fibroblasts in wound contraction and other cells migration and wound repair
activities [131].
Agent Actions
Platelets Secrete TGF-β1, MMP8 and IL-1β to attract other cells.
Neutrophils Secrete TNF-α and MMP8 to attract other Neutrophils and
Macrophages.
Macrophages Secrete TNF-α, TGF-β1, FGF, IL-1β, IL-6, IL-8, IL-10 to attract
Neutrophils, other Macrophages and Fibroblasts.
Clean up cell debris.
Fibroblasts Secrete TNF-α, TGF-β1, FGF, IL-6, IL-8 to attract Neutrophils,
Macrophages and other Fibroblasts.
Deposit ECM proteins to repair tissue damage.
ECM Managers Manages ECM functions and conversion. One Manager per patch.
Table 2.1: Summary of agent rules
2.4.2 Computational Challenges and the Need for HPC in Bio-Simulation
A major challenge of cellular-level simulations for biological systems is dealing
with large data sets. For accuracy, a biologically representative world size and
22
appropriate high-resolution spatial discretization are crucial. In most cases, the
finely discretized simulation space results in the need to maintain billions of dynamic
data points. Thus, high-performance computing (HPC) techniques, language and
hardware resources are needed.
Another significant challenge in systems biology modeling lies in the multi-
scale nature of the model [79, 132–137]. To ensure optimal performance, it is im-
portant for differences in spatiotemporal scales between cellular and chemical inter-
actions to be handled in a cost-effective manner. Cellular movements occur at a
rate of micrometers per hour (µm/h), while cytokine diffusion in tissue occurs at a
rate of micrometers per second (µm/s). A naive approach would be to iteratively
simulate the model at the smallest temporal scale required. However, this approach
would result in a prohibitive increase in the computational cost. A possible solu-
tion is to use coarse-graining techniques to lower the computational intensity [138].
The concept of coarse-graining in ABM refers to the simulation of super-agents
whose rules represent aggregated behaviors of smaller units [139–141]. Our ABM
frameworks use a mechanism that captures the behavior of multiple iterations of
the finer-scale processes, i.e. chemical diffusion, over a coarse time window using
convolution [14, 16]. This intensive computation is then offloaded to a single GPU
while the CPU cores focus on coarse-grain cellular processes.
High-fidelity models produce billions of output data points per iteration. An
effective visualization is the fundamental component to analyzing these outputs by
transforming the enormous set of numbers into an intelligible form. It is also as
essential that the visualization is set up with a protocol that results in the most
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optimal performance. The convention used to be that visualization is performed on
pre-simulated/pre-processed data that is stored on disk; this method is known as
post hoc visualization. However, large simulation data sets have prompted work on
co-processing also known as in situ [142] visualization in order to move the program
to the data as outputs are becoming too heavy and expensive to move around. We
have addressed this issue in [14–16], which will be described in Chapter 5.
2.5 Related Work
2.5.1 Biological System Modeling
Computer simulations have become central to personalized medicine [143–146].
This approach involves the creation of computational models to estimate treatment
outcome and identify the best possible treatment for a given patient. Simulation
modeling involves the integration of the best available knowledge into a computer
platform to represent the real-world problem. The process involves an abstraction
of causal relationships between patient variables and health outcomes followed by a
rigorous and iterative protocol of model calibration and validation [147–149]. The
property that sets numerical simulation models apart from standard statistical mod-
els is the observability of the evolution of patient behaviors and health conditions in
the computer model as time passes during simulation. Such an approach provides
a computational tool for clinicians to evaluate the impact of intervention or other
modifiable variables on health outcomes in advance or along any point during the
intervention.
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Computer models have been developed for complex health conditions, includ-
ing sepsis [150–152], traumatic brain injury [153], acute liver failure [154], dia-
betes [155, 156], obesity [157, 158], and cardiovascular disease [159–161]. In our
case, a series of ABMs have been developed to numerically simulate the essential
biology underlying vocal injury and repair with the goal of helping clinicians to
better tailor treatments for patients with voice disorders [1, 14,74,77,128,130].
2.5.2 HPC ABM for Biological Applications
High-fidelity ABMs in biology (Bio-ABM) often involve large amounts of
data. Multiple high-performance computing (HPC) ABM tools have been devel-
oped to address the challenges in processing these large data sets. For example,
FLAME [162,163] is an implementation of an ABM framework for parallel architec-
tures based on stream X-machines. FLAME has been used to speed up the simula-
tion of ecological systems in various fields including systems biology [76]. FLAME
was further extended with a GPU support [164,165]. SugarScape on steroid [166] is
another example of ABM acceleration on GPU platforms. These tools have demon-
strated their applicability to biological system simulations such as tissue wound
and disease modeling [76, 167, 168]. In the realm of distributed computing, Repast
HPC [169] was developed as an MPI extension to its predecessors, Rapast and
Repast Symphony [170,171]. Repast HPC was adopted to accelerate the simulation
of bone tissue growth [172].
Due to the popularity of ABMs in biological applications, some HPC ABM
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tools have also been developed specifically for biological applications. An example
includes AgentCell, a Repast-based framework for single-cells and bacterial pop-
ulation [173]. The AgentCell framework provides support for running multiple
non-interacting single-cell instances concurrently on massively parallel computers.
Chaste [174] is an example of bio-ABM framework utilizing HPC platforms via var-
ious existing high-performance libraries like PETSs and (par)METIS for parallel
linear algebra and mesh distribution. More examples include HPC ABM frame-
works for multi-core CPUs such as CompuCell3D [175,176], CellSys [177], and Mor-
pheus [178]. In these frameworks, parallelization was performed with OpenMP to
speed up the performance on single-node multi-core CPUs. In addition, other tech-
niques have been proposed to accelerate specific biological models on multi-core
CPUs or GPUs [179–182]. The aforementioned HPC ABM techniques either tar-
get CPUs or GPUs. The inability to exploit both CPUs and GPUs simultaneously
results in sub-optimal resource utilization. Our previous work [14, 16] addressed
this issue by assigning appropriate computational tasks to the CPU while it waits
for the GPUs to complete their computations. However, these previous works only
focused on the simulation computation. This leaves an opportunity in visualization
optimization an open problem.
2.5.3 3D Visualization in Bio-ABMs
The challenge in developing HPC bio-ABM has been relatively well-explored.
However, the same does not apply to the visualization aspect of ABM frameworks.
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Thus, many ABM users resort to a more general data visualization tool such as
Paraview [183] and VisIt [184].
Due to the scales of the data size being generated, the conventional method of
post hoc visualization has become increasingly infeasible. The post hoc method refers
to a visualization process where the visualization is performed after the numerical
simulation has completed. The output data are written to disk during the simulation
and retrieved later for visualization. This visualization method puts an enormous
load on the disk and network. For this reason, another type of visualization, In
situ visualization, has gained the interests of researchers [185]. In situ visualization
allows the outputs to be analyzed on the same machine that produced them. The
ability to perform on-site data analysis reduces the amount of data movements
between the server and remote users. This property makes in situ visualization an
ideal way to visualize simulations that produce large data sets such as our case.
Paraview Catalyst [186, 187] and work reported in [188] are examples of libraries
developed to enable in situ processing of simulation output on popular existing
visualization frameworks such as Paraview [183] and VisIt [184]. A bitmap-based
and a quadtree-based ABM approach [81,189] were proposed respectively to analyze
the numerical output in situ and to reduce non-essential simulation data.
Although atomic-level visualization engines are not visualization frameworks
specific to ABM, some of their optimization techniques can potentially be applied
to a cellular-level ABM visualization framework. For example, MegaMol [190] is
an open-source cross-platform visualization prototyping system. Through low-level
GPU optimizations, a case study shows MegaMol’s capability in visualizing 100 mil-
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lion atoms at the 10 frames per second (fps). CellView [191] is another example of
molecular-level visualization framework designed to process large amounts of data.
With the assumption that the framework will be used for large bio-molecular land-
scapes, CellView employed level-of-details (LOD) and culling technique to achieve
an impressive frame rate of 60 fps on a 15 billion-particle data set. However, Cel-
lView does not support in situ visualization. Thus, the effective frame rate may be
lower if the framework is coupled with a simulation engine.
2.6 Hardware and Software Environment
The computation component of all versions of our 2D VF ABM were tested
and benchmarked on a compute node with 16-core Intel(R) Xeon(R) E5-2690 CPU
and NVIDIA Tesla K20c GPU. The complete simulation suite consisting of both
computation and visualization components were tested and benchmarked on a com-
pute node consisted of a 16-core Intel(R) Xeon(R) CPU E5-2630 and an NVIDIA
Tesla K80 GPU with rendering enabled. All current versions of our 3D VF ABM has
been tested and benchmarked on a compute node with 44-core Intel(R) Xeon(R)
CPU E5-2699 v4 @ 2.20GHz host and two attached accelerators, NVIDIA Tesla
M40. The host has 128 GB of main memory. Each Tesla M40 GPU consists of
3072 cores per device with 24 GB of global memory. Table 2.2 summarizes the
specifications of each GPU used.
To ensure fast and efficient simulation, a lightweight programming language,
C++, is used to implement the program. To utilize the multiple CPU cores available,
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GPU Tesla K20c Tesla K80 Tesla M40
SMs (per Device) 13 13 24
CUDA Cores per SM 192 192 128
Registers per SM 64k 64k 64k
L2 Cache Size 1.25 MB 1.50 MB 3.0 MB
Global Memory (per Device) 4.7 GB 11.25 GB 24 GB
Max Clock Rate 0.71 GHz 0.82 GHz 1.11 GHz
Memory Clock Rate 2.6 GHz 2.5 GHz 3.0 GHz
Memory Bandwidth 208 GB/s 240 GB/s 288 GB/s
Compute Capability 3.5 3.7 5.2
Table 2.2: Summary of NVIDIA Tesla K20c, K80 and M40 specifications
Open Multi-Processing (OpenMP) was used to parallelize tasks to be executed on
the CPU cores. OpenMP is a highly portable Application Programming Interface
(API) supporting multi-threading on shared-memory platforms via a set of platform-
independent compiler directives [3]. In addition, OpenMP was also used to allocate
separate threads to communicate and launch tasks on the GPUs for heterogeneous
hardware concurrency. Computationally demanding tasks to be executed on the
GPUs are managed using NVIDIA Compute Unified Device Architecture (CUDA)
[192] model. CUDA is a parallel computing platform and programming model, which
allows general purpose multi-threaded programming of GPUs via C-like language
extension keywords. In the CUDA language, a GPU is presumed to be attached to
the host (CPU) which controls data movement to/from the GPU. The CPU host
is also responsible for launching CUDA kernels, which are functions to be executed
by all threads launched on the GPU. Open Graphics Library (OpenGL), an open
standard, cross-language API for 2D and 3D rendering, has been used to implement
the simulation visualization. OpenGL is widely used over a broad range of graphics
applications due to its portability and speed. The pre-processing of data to predict
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best parameters for the host-device data minimization algorithm was developed in
Python 3.7.
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Chapter 3: CPU-GPU Task Scheduling
Hardware resource utilization is an important determining factor for software
performance. This chapter discusses the techniques we developed to achieve opti-
mal concurrency of resource utilization at the scheduling level. The chapter begins
with the explanation of the task categorization method which became the basis of
heterogeneous platform task mapping strategies used in this work. The chapter
then expands on task-device mapping strategies designed for 2D, 3D and highly
interactive 3D cellular-level ABMs.
3.1 Task Categorization
The compute tasks are divided into two categories; coarse-grain and fine-grain.
The coarse-grain tasks, such as inflammatory cell functions and ECM protein func-
tions, are best handled by CPUs as they entail more complex computations that
deal with relatively small amounts of data. In contrast, the GPUs are good at the
fine-grain tasks such as the diffusion of chemo-taxins, due to the exceptional ability
of GPUs to process simple tasks that involve large amounts of data effectively.
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3.2 2D Vocal Folds ABM
In our previous publication [14], we proposed a mechanism to hide the diffusion
computation time by utilizing our GPU and p CPU cores concurrently. The details
of CPU threads’ responsibilities are as follows:
i) Allocate p− 1 CPU threads for executing parallel operations other than diffu-
sion.
ii) The remaining CPU thread prepares and manages data movement to and from
the GPU
iii) GPU computes chemical diffusion using FFT-based convolutions (discussed
later in Section 4.2) concurrently with the CPU threads executing their op-
erations
Since all agent decisions during time step t are determined by the state of the
environment determined at the end of time step t − 1, steps (i) and (iii) can be
executed simultaneously as shown in Figure 3.1.
3.3 3D Vocal Folds ABM
The 3D VF-ABM [16] consisted of an environment with 154 million patches.
Each patch stored information of ECM proteins and chemical data. In addition,
around 17 million mobile agents, representing the inflammatory cells, resided in
this ABM world. The model simulated the dynamic biological processes pertinent
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Figure 3.1: Diagram demonstrating CPU-GPU task scheduling scheme for 2D multi-
scale ABM
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to vocal fold inflammation and repair at 30 minute time intervals. At each model
iteration, the operations corresponding to ECM functions, chemical diffusion, and
cell (agent) functions were executed, followed by the update of the ABM world.
Given the computational complexity and the amount of data involved, each itera-
tion required a careful mapping and scheduling of these operations on the available
hardware resources. In addition, the visualization provided essential spatial informa-
tion of ECM proteins, chemicals, and inflammatory cells during the simulation. The
overall goal was to numerically simulate and graphically visualize the 3D VF-ABM
as fast as possible for each iteration.
To achieve optimal resource utilization, it is important to address the chal-
lenges of load balancing, minimizing data movements between the CPU and GPU,
and coordinating the tasks on various devices. As we moved from 2D [14] to 3D [16],
the computational complexity of the simulation and the amount of data involved
increased substantially. Furthermore, the execution time of the visualization com-
ponent, which was negligible in the 2D simulation, became significant. Therefore
the issues of task assignment, load balancing, and device coordination need to be
revisited and addressed properly.
Fig 3.2 illustrates the workflow of the 3D ABM simulation during each iter-
ation. Specifically, it describes the task allocation on a platform consisting of a
single multicore CPU with NGPU GPUs attached to it. For our specific setup con-
sisting of 2 GPUs, the simulation started on the CPU host, and then split into 3
paths: coarse-grain, fine-grain/visualization, and fine-grain. Each of the paths was
run on separate hardware resources. The first path spawned multiple CPU threads
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Figure 3.2: Diagram demonstrating CPU-GPU task scheduling scheme for 3D multi-
scale VF ABM
to execute coarse-grain tasks on CPU cores. The second path was responsible for
visualization and some of the fine-grain tasks that execute on a single GPU resource.
The remaining fine grain tasks executed on the rest of the GPUs. All paths met at
the end to exchange and update the ABM world.
The overlap of visualization and computational components required a care-
ful device coordination as these components now share computing resources. Al-
gorithm 1 describes, at a high-level, how to map tasks and perform host-devices
synchronization. Each GPU task, computational or visualization, has its own CPU
thread for data management and communication with the GPUs. Nested CPU
threads were launched at three levels. At the first level, the driver started the
execution by initializing the simulation and launching two threads, one for visual-
ization and the other for computation. The visualization rendered the current state
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of the ABM world using an available GPU, and then broadcasted the completion of
the rendering task. Concurrently with the visualization execution, the computation
started by launching two more threads at the second level. Both threads at this
level further launched multiple threads at the third level, depending on the number
of cores available. More specifically, the first thread at level 2 was responsible for
executing CPU tasks, which launched parallel threads for coarse-grain task paral-
lelization i.e. level 3. The second thread at level 2 spawned NGPU level-2 threads
to launch fine-grain computation tasks on available GPUs. Note that if the visu-
alization was not yet completed, one of the GPUs would not be available and the
fine-grain tasks would have to wait (Algorithm 2). If a fine-grain task had grabbed
the same GPU used for visualization, it would have to broadcast its completion so
that the visualization can proceed.
3.4 3D High-Interactivity Vocal Folds ABM
The scheduling schemes described in Section 3.3 outperformed other related
ABM works in terms of computational throughput (performance will be discussed
in Section 6.2.1 and 6.2.2). However, since the computational tasks were distributed
among the host and different accelerators, visualization was performed at the end
of each iteration after all data were copied back to the host and synchronized. The
visualization framerate was thus, bounded by the execution time of the computation
and synchronization of the whole iteration.
The scheduling scheme proposed in Section 3.3 was restructured to mitigate
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Algorithm 1: Pseudocode describing CPU-GPU scheduling related functions










10 while !simulationDone do
11 renderOnGPU()
12 visualizationDone← 1 // Notify Computation class of
// visualization completion
13 while computationDone 6= 1 do
// wait for computation on both CPU and GPUs to
complete
14 computationDone← 0 // reset computation completion flag
15 return
16 Function Computation::start():
17 while !simulationDone do
18 launchCPUthreads(2)




23 syncAndUpdateWorld() // Sync CPU and GPU chemical data




Algorithm 2: Pseudocode describing 3D VF-ABM operations and workflow
1 Procedure executeCPUtasks()
/* model computation */
2 launchCPUthreads(p−NGPU − 1)
// p denotes the number of
// available CPU cores
3 for each Patch pt ∈ 3Dworld do




8 for each Cell c ∈ InflammatoryCells do
9 c.cellFunction()
/* model update (excluding chemical data update) */
10 for each Patch pt ∈ 3Dworld do
11 pt.updateECMs()
12 pt.updatePatch()




17 gpu id← thread id
18 if gpu id == gpu idvis then
19 while visualizationDone 6= 1 do
// wait for visualization on GPU to complete
20 visualizationDone← 0 // reset visualization completion
flag
21 for each ChemicalType ct ∈ ChemicalTypeSet[thread id] do
22 diffuseChemicalOnGPU(ct, gpu id) // using GPU FFT library
// (i.e. NVIDIA cuFFT) for
// convolution computations
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Figure 3.3: Diagram showing work flow and scheduling decision of different tasks on
different devices. The coarse-grain tasks gets executed on the host using p−NGPU−1
threads, where p denotes the number of available CPU cores. The CPU host com-
municates with the rendering GPU (GPUvis) to send necessary data for GPUvis to
visualize. Between each visualization frame, GPUvis assists with fine-grain compu-
tations at a subtask level to lighten the loads of other GPUs (GPUcompute), since
these compute GPUs also assist with volume-rendering visualization subtasks to
minimize off-device data transfers.
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the bound on user-simulation interactivity by (1) scheduling GPU tasks at a finer
level to enable (2) GPU hyper-tasking (GHT) [17]. The benefits of GHT are two
folds. First, the GPUs responsible mainly for fine-grain computations (GPUcompute)
can hyper-task between fine-grain computations and ray-casting (visualization sub-
task). This allows the non-screen-attached GPUs to aid in visualizing their local
data and minimize peer communications. Second, GHT allows the rendering GPU
(GPUvis) to lighten the computational loads of its peers by executing leftover fine-
grain subtasks, while maintaining high level of visualization interactivity.
Fig. 3.3 demonstrates the workflow of the proposed scheduling scheme. This
scheme was executed with p CPU threads, where p denotes the number of available
CPU cores. A total of p −NGPU threads were used for coarse-grain computations.
This part remained unchanged from the original 3D scheduling schemes. In the
3D high-interactivity scheme, the rest of the threads were not simply launching
fine-grain tasks, but rather communicating with the rendering GPU (GPUvis) and
compute GPUs (GPUcompute) to orchestrate GHT.
The program used NGPU − 1 threads for communications with the GPUs re-
sponsible mainly for fine-grain computations (GPUcompute). Each time a GPUcompute
completed its fine-grain task, the GPU compressed the output and buffered it for
visualization in the next iteration. In addition, these GPUs participated in vi-
sualizing their local data from the previous iteration when they finish a task by
performing ray-casting locally. Each GPUcompute then sent the results as GLtexture
to the GPUvis for rendering. This prevented the GPUs from having to send large 3D
volumetric data to their peer, and only send ready-to-render 2D textures to GPUvis.
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One thread was spared for communication with GPUvis. The main respon-
sibility of GPUvis was to perform graphical visualization of all numerical outputs
including those residing on the CPU host and other GPUs (GPUcompute). However,
between visualization frames, GPUvis switched to compute mode to assist in fine-
grain computations. Since, other GPUs (GPUcompute) spared some of their resources
to assist with the visualization process to reduce amounts of data being sent off-
device, it was necessary for GPUvis to lighten the loads of other GPUs whenever it
can for optimal performance.
Our tested configuration consisted of one multi-core CPU and two GPUs.
However, this scheduling scheme could be extended to work with more than two
GPUs by executing the scheduling logic of GPUcompute shown in Fig. 3.3 on addi-
tional GPUs. The added GPUs would be beneficial if the execution time of the
fine-grain tasks on GPUs exceeds that of the CPU coarse-grain tasks. This schedul-
ing scheme would thus, scale out with additional GPUs as the amount of fine-grain
tasks increases.
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Chapter 4: Numerical Simulation Optimizations
A challenge in biological simulation is to handle the differences in spatiotempo-
ral scales between cellular and chemical interactions [79]. To address this challenge,
we designed a mechanism to compute the processes with finer spatiotemporal steps
(chemical diffusion) at the scale comparable to the cellular level processes. Cellular
functions and chemical diffusion were then optimized separately for execution on
multi-core CPU and GPU, respectively.
4.1 Cellular Functions
Cellular level processes such as cell migration and protein synthesis are com-
plex, but relatively less data-intensive compared to chemical diffusion. Thus, these
functions were optimized using OpenMP to be executed on the CPU cores. This sec-
tion describes two main optimization approaches used to fully leverage parallelism
on a shared memory multi-core device: concurrent containers and parallel update
mechanisms.
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4.1.1 Concurrent Cell Container
The program maintains pools of biological cells (ABM agents). The agent
pools can expand or shrink due to cell proliferation and cell deaths. The C++
std::vector was originally used to maintain the pools of biological cells in the
sequential version. However, when cell related functions were parallelized, this con-
tainer of choice became the bottleneck of the program. There exists a concurrent_vector
class which is thread-safe, unfortunately, there is no support for parallel deletion
making the deletion of dead agents nonparallelizable. To alleviate this limitation,
a custom data structure, ArrayChain was developed. The goal is for this new
thread-safe container to manage an agent pool with concurrency and perform all
agent-related operations in O(1) on average. The concurrency was achieved with-
out the need for explicit mutual exclusion through the requirements that the set of
agents accessed by each thread does not overlap with that of any other threads. The










Listing 4.1: Code snippet for definition of nodes in ArrayChain
Members:
• T* data[MAX_ARR_SIZE] stores the actual data (cell pointers)
• vector<int> freeLists[NUM_THREADS] stores lists of indices of free slots
in data. Each vector contains best effort information local to each thread.
freeLists[tid] only contains indices of the slots in data that has been emp-
tied out by thread with id tid. Thus, each list or even all of them combined
may not be exhaustive.
• struct ArrayChain* next stores a pointer to the next node in the chain. NULL
if this is the last node.
• int numFreeApprox stores a number of contiguous elements at the end of the
list. This is used when threads request for parallel batch insertion to data.
For example, in Fig. 4.1, there are 589 slots at the end of data that are free
and contiguous, thus parallel batch prefix sum insertion of total number of
elements of at most 589 can be performed in node 2 of the chain.
Agent Insertion: Let's say thread tid would like to add a new agent to the
list. It would call insert(), described in Algorithm 3 in an attempt to add to a
recycled slot (from its freeList). If insert() returns true, then this new agent
was successfully added. If it returns false, then thread tid will attempt to add this
new agent (and other agents it has not added) through a participation in parallel
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prefix insertion with other threads.
Algorithm 3: ArrayChain single-element insertion and deletion algorithm
1 Procedure insert(ArrayChain agentList, Agent newAgent)
2 for each ArrayChainNode arrNode ∈ agentList do
3 if ¬arrNode.freeList[tid].isEmpty() then
// empty recycled slot found
4 index← arrNode.freeList[tid].pop() // get index of free
slot
5 arrNode.data[index] ← newAgent // add agent
6 return true
7 return false




12 for counter = 1 to agentList.size() do
13 arrNode← arrNode.next
14 arrNode.data[nodeOffset] ← NULL
15 addNode.freeList[tid].push(nodeOffset)
Prefix sum insertion happens when at least one thread ran out of local free
indices. When this happens, the program will perform prefix sum on the array
45
containing number of elements each thread would like to add to the list. Once the
prefix sum is performed, each thread will then have the correct offset to data in the
last node of the chain so they can all insert their elements in parallel.
If numFreeApprox is less than total number of things to add, then:
• Add number from (MAX_ARR_SIZE - 1 - numFreeApprox) to (MAX_ARR_SIZE
- 1) to freeLists[0]
• Allocate new node
• Add all elements to data in the new node in parallel
Notice that to insert a single agent, if a thread finds an empty slot through its
freeList the thread does not have to wait for any other thread (full concurrency)
and the operation complexity is O(1). If the thread has to participate in a prefix
sum parallel insertion, the complexity is still O(1), concurrency is still maintained,
however, the prefix sum computation becomes the execution barrier. The prefix
sum computations themselves are constant as the complexity is proportional to the
number of CPU threads. The worst case is when it has to iterate through all the
nodes in the ArrayChain, the complexity becomes O(m), where m is the number of
nodes which is roughly n
MAX ARR SIZE
, assuming constant size nodes.
Agent Deletion: Deletion of a single agent takes clearly constant time with
full concurrency, as it simply frees the agent space and marks entry NULL, then adds
the entry index to the freeList.
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Figure 4.1: An example of ArrayChain of macrophages (mac) with two nodes.
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4.1.2 Update and Synchronization
All agents make decisions in time step t based on the state of the system in
time step t− 1. Each agent then modifies its own state in time step t according to
the decisions made in the same time step. Consequently, there is little to no data
dependency in the process of state update for each agent for any specific time step,
making ABM simulation an excellent candidate for parallelization. However, as the
simulation progresses, constant updates are unavoidable causing heavy traffic to
memory. In order to mitigate memory bandwidth contention, each agent maintains
dirty flags, and each agent only updates when necessary.
Apart from writing to their own fields, agents’ decisions also affect their envi-
ronment. If we assume that the resolution of the world is the finest possible, each
patch will only allow one agent. When an agent targets a patch to move into, it needs
to make sure that no other agents will move into that patch. Naively, one could
maintain a lock for each patch; however locks incur a high overhead. For optimal
performance, atomic operations were used for synchronization to enforce the rule of
one agent per patch as shown in algorithm 4. The function atomic test and set(v)
atomically sets the content of v to true and return the previous value of v, thus an
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agent can find out if the patch is available by checking the return value.
Algorithm 4: Agent Atomic Move
Input: P = target patch
Output: rc = true if move was successful, false otherwise
1 if ¬atomic test and set(P.isoccupied) then
2 this.x← P.x;





Chemical diffusion was the most demanding computational component of the
VF ABMs. As previously mentioned, its computational demand was primarily a
result of the extremely small spatiotemporal scale and high rate at which chemical
diffusion occurs. To reduce the computational load, a convolution-based method
was used to simulate the diffusion process [14]. A Fast Fourier transform (FFT) was
then used to reduce the complexity of convolution computations. Lastly, kernel size
reduction was achieved by extracting the most dense segment of the Gaussian kernel
to optimize the diffusion performance [16]. Note that, since we deal with regular
grids for the ABM world, finite difference method (FDM) is used as opposed to the
more computationally intensive integral schemes.
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4.2.1 Discrete Finite Scheme












where c is the chemical concentration, D is the diffusion coefficient and γ is the
















Assuming that ∆x = ∆y = ∆z, and using a Taylor expansion to discretize
the continuous 3D diffusion equation, we get






c (x, y, z, t) +
D∆t
∆x2
[c (x+ ∆x, y, z, t) + c (x−∆x, y, z, t) +
c (x, y + ∆y, z, t) + c (x, y −∆y, z, t) +
c (x, y, z + ∆z, t) + c (x, y, z −∆z, t) ] (4.3)
Using Von Neumann Stability Analysis method to study the growth of the
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4.2.2 Convolution Based Diffusion
As shown in Table 4.1, the largest value of D in the set of chemical types
in VF ABM is 900 µm
2
minute
[194], with patch width ∆x = 15µm. The condition
∆t ≤ 2.5 s needs to hold to meet stability constraints. Clearly, the complexity of
the simulation using discrete finite scheme would be unnecessarily high if the model
evolved at ∆τ = 2.5 s rather than ∆τ = 30 min or 1800 s.
By letting λ = D∆t
∆x2
, Eq (4.3) can be rewritten as
c (x, y, z, t+ ∆t) = (1− 6λ− γ∆t) · c (x, y, z, t)
λ · c (x+ ∆x, y, z, t) + λ · c (x−∆x, y, z, t) +
λ · c (x, y + ∆y, z, t) + λ · c (x, y −∆y, z, t) +
λ · c (x, y, z + ∆z, t) + λ · c (x, y, z −∆z, t) (4.5)
or,







c (i, j, k, t) · f (x− i, y − j, z − k) , (4.6)
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where
f (x, y, z) =






















Clearly, Eq (4.3) is equivalent to Eq (4.6), thus c (x, y, z, t+ ∆t) = c (x, y, z, t)∗
f (x), where ∗ represents convolution. This results in the ability to fast forward this
process to capture diffusion at a large time step, ∆τ , without violating stability
constraints using convolution.
To compute c (x, y, z, τ + ∆τ), where ∆τ = m · ∆t, the chemical concentra-
tions from previous step, c (x, y, z, τ), was convolved with f (x, y, z), m times. The
commutative property of convolution implies that convolving f (x, y, z) with itself
m times results in fm (x, y, z), and the diffused concentrations at each iteration can
be computed as
c (x, y, z, τ + ∆τ) = c (x, y, z, τ) ∗ fm (x, y, z) . (4.7)
The diffusion computation can thus be accelerated by computing Eq 4.7 at a
large time step, ∆τ , without violating stability constraints. The effective diffusitivity
of IL-1β in tissue, for example, is 900 µm
2
min
[194]. In a 15 µm patch world, a 30-minute
time step implies that the program has to calculate c (x, y, z, τ)∗f720 (x, y, z) at each
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time step. In other words, a chemical on a given patch (x,y,z) has a spatial diffusion
range of x±720, y±720 and z±720, within a window of dimension 1441×1441×1441,
which covers approximately 3 billion patches.
After obtaining the formula for fast-forward diffusion calculations, we need
to also consider boundary conditions to appropriately pad the data for convolution
operations. Depending on the area of interest, the padding chosen could either be
constant padding or mirror padding or both.
In our case study of vocal folds modeling, our tissue area of interest has ep-
ithelium on the outermost layer. This means we have effectively one wall, or 1-side
0-flux boundaries. And the rest of the walls can be padded with empirically ob-
tained baseline chemical levels, or constant padding. The convolution computation




TNF-α TGF-β1 FGF MMP8 IL1 IL6 IL8 IL10
900 780 780 780 900 810 900 900
Table 4.1: Effective diffusion coefficients used in VF ABM. TNF-α, TGF-β1, IL1
and IL6 values were taken from [194].
4.3 Kernel Reduction
The diffusion kernel was computed by convolving the initial coefficient func-
tion, f(x, y, z), in Eq (4.6), with itself m = ∆τ/∆t times, where ∆τ is the biological
time step of 30 minutes and ∆t = ∆x2/6D is the diffusion time step subjected to
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Figure 4.2: Diffusion kernel reduction mass vs. kernel width. This plot shows mass
coverage with respect to extracted window width. The size of each kernel is width3
patches. It is observed that by cutting down the size from 14413 down to 1473, only
a fraction of 0.0061 of the mass is lost in each iteration.
the stability constraints (Eq 4.4). As calculated earlier, the effective diffusitivity of
IL-1β of 900 µm
2
min
results in a 1441× 1441× 1441 kernel.
Note that f(x, y, z) is smoother as it gets convolved with itself, thus a Gaussian
shaped diffusion kernel is obtained. The values in Gaussian distributions are highest
at the center. These values decrease and approach zero, the further they are from
the center. This observation enabled the reduction of the kernel size by focusing on
the center window, while keeping almost 100% of kernel mass. The coverage levels
of the kernel mass with respect to extracted window sizes are plotted in Fig 4.2.
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Chapter 5: Visualization Optimizations
5.1 In Situ Visualization Protocol
In recent years, as the computational power of computing platforms has sub-
stantially increased, numerical simulations developed on these platforms have grown
much more complex, generating outputs that measure up to hundreds of terabytes
in sizes (and soon exabytes) [192]. Conventional visualization work-flow of writ-
ing output to disk for later visualization is not really a cost effective solution for
such cases. To design a simulation framework that scales with the computational
power of the latest platforms, a compute-visualize paradigm satisfying the following
properties will be extremely desirable.
1. Both the computation and the visualization will take full advantage of com-
putational power of the server;
2. The load on the disks should be minimized;
3. The researcher should be able to steer the computation based on the data as
it is being generated and visualized.
The local simulation, as previously discussed, can rarely take advantage of the
server as it assumes direct connection between the compute node and the display
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and it is uncommon for the user to have physical access to the server. On the
other hand, conventional work-flow remote simulation may be able to partly take
advantage of the powerful server, but it does not exhibit neither property 2 nor
3. Lastly, the client-render remote simulation scheme may manifest both 2 and 3;
however, it does not fully take advantage of the powerful server since it redirects
the rendering to the client.
The In Situ Remote Visualization paradigm [142] exhibits all three of the
desired properties. Our ABM implementation was developed and tested on a system
configured with VirtualGL and TurboVNC. VirtualGL is an open source package
that gives any Unix or Linux remote display software the ability to run OpenGL
applications with full 3D hardware acceleration [196]. Figure 5.1 shows the X11
transport with an X proxy diagram. The application uses Xlib to communicate with
the 3D X server to request for an openGL context. Once the context is created,
the application can then talk directly to the rendering hardware via libGL. An
X proxy, in our case TurboVNC, essentially acts as a virtual X server. The X11
rendering is then performed to a virtual framebuffer in main memory rather than
a real framebuffer on the graphics card. This allows the X proxy to compress and
transmit the buffer content to end user without the need to provide any X server
capabilities, thus a very thin client can be used.
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Figure 5.1: Diagram depicting the system configuration for In Situ remote visual-
ization using X11 transport with an X proxy.
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5.2 Data Access Pattern Observations and Categorizations
For optimization purposes, we categorize a dynamic pattern of a data type
based on two properties. First, a data access pattern is defined by the distribution
characteristics in a single iteration. For example, the distribution of a chemical
concentration is typically smooth due to diffusion, whereas ECM protein and cell
distributions exhibit some degree of discontinuity. Second, the dynamics are defined
by how the distribution changes from one iteration to another, for example localized
versus distributed changes. Table 5.1 shows the categorization of dynamic patterns
for the different types of output and which device they were computed on.
Smooth Discontinuous
Localized 0—n/a I—ECM Proteins
Distributed II—Chemicals III—Cells
GPU CPU
Table 5.1: Data dynamic pattern categories
Notice that none of the patterns observed in wound healing ABMs fall into
category 0. Data type that are discontinuous and distributed fall into category III.
Examples include mobile agents such as neutrophils, macrophages and fibroblasts,
or non-mobile agents such as platelets. In this work we focused our optimization
efforts only on protein (signaling chemicals and ECM) data that fall into category
I and II.
Data category I are quantities that do not diffuse or spread, thus changes
are typically local with discontinuous distributions. These are mostly structural
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quantities. For example, ECM proteins form an underlying structure of the tissue
and provide building blocks of the overall structure similar to laying out bricks for
a building. Once a brick is laid, it stays there until it is degraded or destroyed.
In wound-healing models, these quantities are localized, and thus changes to these
quantities happen mostly in highly-active areas such as wound sites.
In contrary, category II data diffuse or spread, thus their distributions are typ-
ically smooth. Once the mass gets deposited at a location, it undergoes immediate
changes in concentrations and reaches other areas. This includes diffusible quan-
tities such as chemicals, gas, and heat. The dynamics of these quantities are very
distributed in nature. The changes usually keep happening and affect other areas
until an equilibrium is reached. However, in wound healing models, inflammatory
cells may not stop protein secretion until they return to homeostasis [197]. Thus, an
equilibrium may not be reached until the end of the simulation, resulting in constant
changes all over the simulation area.
5.3 Data Access/Update Minimization Technique
5.3.1 Data Category I
As discussed in the previous section, this type of data involves structural
change and the outputs reside on the CPU host. These data, thus, need to be
copied from CPU to GPUvis during visualization. Structural data change locally
i.e. the change in one location does not directly impact other locations. More
specifically, in wound healing models, most activities occur in the damaged areas.
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Figure 5.2: An example sequence demonstrating the Host-Device Activity-Aware
Data Copy (HADC) technique to minimize the transfer of redundant category I
data. First, the 3D ABM world gets divided up into smaller sub-volumes. In each
iteration, when a patch is modified, the parent sub-volume gets identified. The
corresponding entry in the activity map gets marked as ’dirty’. Only the ’dirty’
sub-volumes get copied to the GPU for visualization.
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Given these observations, we developed a Host-Device Activity-Aware Data Copy
(HADC) technique to reduce the copying of redundant data.
5.3.1.1 HADC Algorithm
Fig. 5.2 demonstrates the work flow of HADC during the simulation. First,
the ABM world is divided into smaller sub-volumes. In each iteration, when a patch
gets modified, the program identifies the parent sub-volume of that patch. The
algorithm then looks up the corresponding entry in the activity map and increments
its activity index. During the data buffering stage, only the data in the sub-volumes
that had gone through significant changes get copied to the GPU for visualization.
In this way, the amount of redundant data copies is minimized, resulting in a faster
buffering process.
5.3.1.2 HADC Sub-Volume Size Recommendation Heuristic
The size of the sub-volumes is a very important factor in determining the per-
formance of HADC. If the size is too large, a large amount of unnecessary data copies
will be performed. However, if the size is too small, since each small sub-volume
will be copied in a separate transaction, the latency of host-device copy operations
will hurt the overall performance. To find an optimal partition, the program runs
the model, and logs the locations of activities in each iteration. For a given M
points (representing activity locations) in a log from the most active iteration, the
goal is to find a partition of size w × h × d, where the M points appear in as few
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partitions as possible. In other words, the objective is to minimize the partition size
(space) and number of communications (time) between host and device, where the
two extremes are < O(WHD)space, O(1)time > and < O(1)space, O(M)time >.
To determine a good partition size, a modified octree algorithm is used. This
heuristic consists of two passes: top-down and bottom-up. At the end of each pass,
each node (partition) will either be labeled white (insignificantly low density) or
black (significantly high density). The first pass starts top-down from the whole
simulation grid, and split on the density conditions given the parameters ρlow and
ρhigh. Once the program is done splitting as all nodes satisfy one of the density
conditions (node density < ρlow or > ρhigh), the program will return a list of black
node dimensions. Here, the smallest volume dimensions will be picked to minimize
the partition size. The program then execute the second pass in an attempt to
combine consecutive partitions if and only if the density condition requirements still
hold. This bottom-up pass is executed to further minimize the number of host-device
communications.
Given a wound healing model m =< wc,mc, ic, r >, where wc denotes the
wound configuration (dimensions, wound location), mc denotes model configuration
(dimensions), ic denotes the initial conditions (patients cytokine levels, treatment
type etc.) and r denotes the model rules, if we know the optimal subvolume size of
m, then we can choose a scaled subvolume size for model m′ =< wc′,mc, ic′, r >.
For example, if the wound depth of m and m′ is 1 mm and 0.5 mm respectively in
the x-direction, then we can scale the optimal subvolume size of m in the x direction
by 1
2
and reuse it for m′. This way, once we determined an optimal subvolume size
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for model m, we can apply it to any model m′ defined earlier.
5.3.2 Data Category II
The computations of diffusible quantities involve relatively large amounts of
data, thus they were performed on GPUs. These output data are, thus, local to
the GPUs. Two approaches were used to reduce data access: host-side sampling
and device-side sampling. The host-side sampling minimizes number of data points
accessed before the OpenGL rendering functions get called through constant and
adaptive sampling.
To lower the amounts off-device data copies, the device-side sampling scheme
compressed and store computed data on the producer GPU using linear sampling so
each GPU can assist in ray-casting. The details of both schemes will be described in
the following sections. The performance improvement and accuracy trade-offs are
discussed in Section 6.3.
5.3.2.1 Host-Side Sampling
The first host-side sampling approach is simply constant sampling. The world
environment is divided into tiles of size gridx×gridy×gridz , where the correspond-
ing grid point represents the values of the tile centered at the point and within the
radius of gridx/2, gridy/2 and gridz/2 in the x-, y-, and z-dimension, respectively.
This naive approach was used to improve the visualization speed in our earlier
work [16]. At the perspective of the entire simulated volume, the appearances of
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sampled simulation were indistinguishable for up to (6 × 6 × 6)-segment sampling.
However, the output became pixelated when the view is magnified and the camera
focuses on a smaller area. In particular, the wound area was not rendered with
reasonable fidelity.
Adaptive sampling is used to optimize the data access while enhancing the
resolution of the visual output in important areas. This sampling scheme helps keep
the execution time low, and yet the details in the output presented are not compro-
mised. The details of execution time and visualization outputs will be discussed in
Section 6.2.2.2.
For models aiming to capture injury undergoing inflammation and repair pro-
cesses, the wound site is the most active area. Therefore, the highest importance
index was assigned to the wound site volume. The margin around the wound site,
and the rest of the tissue are then respectively assigned less and least importance.
The adaptive sampling pipeline diagram in Fig 5.3 illustrates data processing steps
used to sample and send data to the visualization pipeline. The program, by de-
fault, divides the whole tissue volume into three sections by first inspecting the
initial wound position and size, followed by adding a margin around the wound
based on user inputs, and then labeling this volume as the most active (region 1).
The program lets the user specify the volume ratio between medium- and low- ac-
tivity area, and splits the rest of the volume into regions 2 and 3 accordingly. As our
visualization intends to highlight wound activity, the re-sampling is performed only
once, thus the memory footprint is not heavily affected by the re-sampling process.
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Figure 5.3: Adaptive sampling pipeline. From the whole set of data (left), the data
are read with resolution conforming to the importance index (middle). The sampled
data are then processed and sent to the visualization pipeline to be rendered (right).
5.3.2.2 Device-Side Sampling
In multi-scale simulations, the diffusion is a fine-grain process and is most
suitable to be executed on GPUs. Thus, the data needed by the visualization would
have been temporarily stored in the GPU memory at some point. An ideal situation
would be to save the diffusion output on the GPUs. Storing data on the GPU will
make the data available for visualization throughout each given iteration. However,
the size limitation of GPU memory may not allow the storage of all data points in
large data simulations.
To avoid off-device data visualization, the buffer size needs to be reduced to fit
on the GPU. Here, the data size is reduced through a simple constant sampling pro-
cess. The output gradient details are then preserved by taking advantage of the GPU
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texture memory. Through the CUDA texture filter mode, cudaFilterModeLinear,
a sample fetched from a CUDA texture is automatically interpolated [198]. This
functionality of texture memory helps preserve the temporal dynamics of the output
by filling in the gaps between sampled points with interpolated values. Note that
CUDA does not allow write operations through a texture reference. Thus, sampling
from GPU memory to a texture will need to be performed via a surface reference
bound to the same CUDA array.
One may argue in favor of more complex data sampling and interpolation
methods. However, as those methods improve the accuracy of the sampled data, they
also add complexity. In large data simulations, millions to billions of data points are
being visualized in each frame. With such large amounts of data points, the added
accuracy may not be visible. Thus, we studied the image quality versus execution
time and report our findings in Section 6.3. It appeared that the simple sampling
with the help of CUDA texture produced visualization that looked indistinguishable
to the original data and maintained acceptable accuracy of 95%. Thus, we did not
deem it necessary to add more complexity to the program in this context.
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Chapter 6: Results
To evaluate the techniques proposed in previous chapters, this chapter begins
with a section describing configurations of 2D, 3D and highly-interactive 3D VF
ABMs. The performance improvements gained using different sets of techniques
described in Chapter 3, 4, and 5 are then discussed for each respective model. Next,
the chapter studies the performance-accuracy trade-offs for sampling techniques
described in Section 5.3.2. Finally, the chapter ends with the details on model
verification.
6.1 Model Configurations
We have developed VF ABM models for two different mammals: rat (3D) and
human (2D and 3D). The rat 3D VF ABM serves as a test model due to its size and
the availability of empirical data. The model configurations were determined based
on empirical data and vocal fold literature reviews [108, 199–204]. Table 6.1 lists
the scale of the 2D and 3D VF ABMs implemented in this work. In addition, the
details of the set of techniques used in each model is listed in Table 6.2. These tables
serve as references in terms of simulation scales and optimizations for performance
evaluation that will follow in later sections.
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Item Unit 2D Human 3D Rat 3D Human
World
Size patches3 1660 x 1160 x 1 71 x 200 x 142 1390 x 1006 x 110
mm3 24.9 x 17.4 1.4 x 1.0 x 0.5 20.85 x 15.09 x 1.65
Patch size µm3 15 x 15 x 1 7 x 7 x 7 15 x 15 x 15
Total number 106 units 1.9 2.0 154
of patches










Neutrophils 106 cells 0.023 0.0005 1.72
Macrophages 106 cells 0.023 0.0003 0.97
Fibroblasts 106 cells 0.184 0.0035 12.20
Simulated time-step minutes 30 30 30
Table 6.1: Summary of 2D and 3D VF ABM configurations
6.2 Performance Evaluation
6.2.1 2D Human Model
6.2.1.1 Computation Only Performance
Different versions of 2D VF ABM were implemented for performance evalua-
tion purposes as shown in Table 6.3. These versions follow the same model rules,
but differ in computing resource utilization. They were tested and benchmarked on
a compute node with 16-core Intel(R) Xeon(R) E5-2690 CPU and NVIDIA Tesla
K20c GPU.
As shown in Figure 6.1, the GPU-mCPU-Overlap implementation achieves the
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OpenMP parallelization 4.1 X X X
FFT convolution-based dif-
fusion
4.2 X X X
Kernel reduction 4.3 X X
In situ visualization 5.1 X X X
HADC 5.3.1 X
Host-side sampling 5.3.2.1 X
Device-side sampling 5.3.2.2 X
Table 6.2: Summary of techniques used in each VF ABM implementation
Tasks Executed on
Implementation Single-core CPU Multi-core CPU GPU
sCPU-sCPU Diffusion - -
Other functions
mCPU-mCPU - Diffusion -
Other functions
GPU-sCPU Other functions - Diffusion
GPU-mCPU - Other functions Diffusion
GPU-mCPU-
overlap
- Other functions Diffusion
Table 6.3: Summary of 2D VF ABM implementations
best performance. This implementation follows the techniques discussed in Section
3.2, where the ABM model execution is being divided up into smaller more manage-
able tasks that are either high-throughput computationally-intensive or complex,
but less computationally intensive. The former is considered GPU-suitable, thus
is executed on the GPU, whereas the latter gets executed on the CPU. The CPU-
suitable tasks are then further sped up by multiple CPU threads. The total time to
execute one iteration of the program is governed by the following equation:
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Figure 6.1: Performance of 2D Vocal Fold Inflammation and healing ABM on dif-
ferent processing platforms.
ttotal = max{tCPUmaxthreads , tGPUmaxthreads}+ tsync, (6.1)
where tCPUmaxthreads and tGPUmaxthreads are the time consumed by executing
tasks using maximum number of threads on CPU and GPU respectively. The max-
imum number of threads typically corresponds to the number of physical cores on
the specified computing device. tsync is the time it takes to synchronize the data
resulting from task executions on CPU and GPU. If tdevice1maxthreads ≥ tdevice2kthreads ,
then clearly, any number of threads launched beyond k threads on device2 would
not benefit the overall performance. For the vocal folds simulation on the aforemen-
tioned compute node, tGPUmaxthreads ≥ tCPU8threads , thus the load is most balanced
when executing with 8 CPU threads.
Our implementations are able to execute the 2D VF ABM at a scale that is
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infeasible on a popular existing ABM framework, NetLogo [205]. To demonstrate
the performance gain of the proposed techniques compared to an existing ABM
framework, we obtained the performance of the GPU-mCPU-overlap implementa-
tion running at a scale feasible on NetLogo. For a 1-million patch world, with half
number of initial cells, the model ran on average 36.6 s per iteration on NetLogo
and an average of 0.091 s per iteration on the GPU-mCPU-overlap implementation,
resulting in a 400x speedup.
Despite differences in underlying hardware, D’Souza’s work on Tuberculosis
(TB) ABM Simulation [75] was arguably most suitable for performance comparison
with the work reported in this paper. The aforementioned TB ABM described
a complex multi-scale biological system of agents that communicate via chemical
signals, which aligned in most respects with our model. The largest case reported in
their work consists of 256 patches x 256 patches world with 100 initial Macrophages,
and takes 450 seconds to run for a 4-day simulation. In comparison, our case study
consisted of 30x world size with 1000x the number of initial cells, and took only 25
seconds, i.e. 20x less, to perform a 4-day simulation.
Next, we compared the performance improvement gained by the GPU-mCPU-
overlap implementation over other low-level highly optimized implementations. A 5-
day high-resolution simulation that took 20 minutes on CPU only took half a minute
when both CPU and GPU are efficiently utilized via our proposed task orchestration
technique, accounting for a 35.1x and 6.6x speedup in execution time over single-
core and multi-core CPU respectively. This improvement was significant given the
fairly complex and biologically representative 2D model with intensive calculations
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and heavy memory traffic.











Rendering + Image Transmission 47
Total 189
Table 6.5: Average execution time of remote in situ 2D VF simulation
6.2.1.2 Computation-Visualization Performance
The GPU-mCPU-overlap computation implementation, which shows the best
performance from section 6.2.1.1 was coupled with visualization code implemented
with OpenGL. The advanced visualization component displays aggregated statis-
tics and simulation state of multiple components over spatio-temporal dimensions
simultaneously. This complex simulation suite (Figure 6.2, 6.3) was then tested
and benchmarked on a compute node which consists of a 16-core Intel(R) Xeon(R)
CPU E5-2630 and an NVIDIA Tesla K80 GPU with rendering enabled. As shown
in Table 6.5, average execution time per tick, which includes complex simulation
computation and rendering on the server, takes a little bit less than 200 ms. Vir-
tualGL and TurboVNC enable simulation frames to be transmitted to the end user
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Figure 6.2: A screenshot of a running 2D human vocal fold inflammatory and wound-
healing process with aggregated chemical statistics plots and chemical visualization
on (heat map and surface plots)
Figure 6.3: A screenshot of a running 2D human vocal fold inflammatory and wound-
healing process with aggregated chemical statistics plots and ECM visualization on
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with very minimal overhead. Therefore, the total time to simulate, visualize, and
render outputs on the client terminal can be kept under 200 ms per iteration.
6.2.2 3D Human Model
6.2.2.1 Computation Only Performance
Due to the efficiency of the FFT-based diffusion method, diffusing 1.2 billion
point 3D chemical data on two GPUs only takes 2.5 s per iteration. Since the set
of cellular coarse-grain tasks take about 4 s to execute, these tasks become a perfor-
mance bottleneck. That is, the time the VF ABM takes to complete the computation
component of one single iteration depends on how long it takes to execute the cel-
lular tasks plus time to synchronize results. Fig 6.4A shows the execution time for
the compute component as a function of number of CPU threads overlapping with
two GPUs. These results indicate that the best performance using 32 threads takes
approximately 6.2 s per iteration on average. The average speedup of the computa-
tion component as well as compute-task speedups across 240 iterations over different
numbers of threads are plotted in Fig 6.4B. Tasks are grouped into model function
(cell/ECM/synchronization) and update routines, and their speedups within each
respective group were then averaged. Notice that the update tasks which consist of
mostly memory access operations are memory bound, thus showing poor scalability.
In contrast, other model function tasks involve more computation, thus these tasks
show good scalability, making the overall speedup of the program satisfactory.
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Figure 6.4: 3D VF ABM computation-only performance scalability. Graphs showing
(A) execution time and (B) speedup of the 3D VF ABM as a function of number
of threads. Notice that the average speedup of model function routines (orange
dotted) is much higher than that of the update routines (grey dotted). This is
because, as opposed to the update routines, the model function routines perform
more computations than memory access operations. Even with some memory-bound
functions, the overall speedup of the program (blue solid) is still satisfactory.
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6.2.2.2 Visualization Only Performance
Since coarse-grain tasks (excluding updates) take about 4.7 s while fine-grain
tasks on the GPUs only take 2.5 s, there is an idle period on the GPUs waiting
for the CPUs to finish the coarse-grain tasks. Our goal is to make the visualiza-
tion component fast enough so that the 2.2-second window gap would allow us to
integrate visualization with computation on the GPUs without increasing the total
execution time.
The visualization component includes cell migration, chemical diffusion, and
tissue damage tracking. The most time consuming component is the chemical diffu-
sion, which requires an access of 154 million points of data during each iteration. As
discussed earlier, data sampling was used to improve the visualization performance.
The plot in Fig. 6.5 shows the execution time and screenshots of chemical visualiza-
tion using different sampling window widths. The visualization of the entire world
looked almost identical for up to 63 sampling windows. Results showed that looking
at the entire simulation area, enough information was retained by using 63 sam-
pling. By using host-side constant sampling, the visualization runtime of chemical
diffusion went down significantly from 23 s to 0.4 s.
There are circumstances in which the users may want to zoom in to see chem-
ical distribution around the most active area, namely the wound area. For this, we
can use adaptive sampling to provide higher resolution to the wound site, to en-
sure smooth images even when zooming in while keeping the performance optimal.
Observed from the visualization view of the entire simulated volume using constant
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Figure 6.5: 3D VF ABM visualization-only performance. This chart shows visualiza-
tion screenshots and corresponding execution time for different sampling resolution.
The stride denotes the gap between two consecutive sampled points, thus the higher
the stride the coarser the sampling. The visual appearance of the each sampling
case looks almost identical for up to stride 6 or 63 sampling windows. Enough
information can be retained by using 63 sampling.
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Figure 6.6: Screenshots comparison of 63 constant sampling windows (left) and
2− 4− 6-adaptive sampling resolution (right) when zoomed in to high-activity area
sampling, the appearance of sampled simulation was indistinguishable from 13 up to
63 sampling. Thus, for optimal performance, the least important areas in adaptive
sampling are set to use the coarsest resolution of 63 sampling windows. The medium
and most important areas are then sampled with finer 43 and 23 windows, respec-
tively. With 2−4−6-sampling resolution, as shown in Fig. 6.6, the resolution of the
visualization improved significantly, while the execution time of the visualization
component only increased to 1.9 s (from 0.4 s), which is still below our visualization
time budget, hence no increase in the overall execution time.
6.2.2.3 Computation-Visualization Performance
Since the visualization execution time was reduced from 23 s down to 0.4 s
using data sampling for chemical diffusion, the visualization execution could then
be placed in the idle period on one of the GPUs. By placing the visualization
execution in a GPU idle gap, the total execution time remained unchanged at 6.2 s
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per iteration on average. This fast execution time enabled the simulation to execute
remote computation, remote visualization, remote transmission of the result frame,
and frame rendering on the client’s machine in under 7 s/frame. This performance,
as far as we know, is the fastest known complex ABM simulation and visualization
at a similar scale.
For benchmarking purposes, the 3D VF ABM was compared to our previous
and other ABM works of similar nature (Fig 6.8). The M. Tuberculosis (MTb) ABM
[75] was benchmarked on a system with an NVIDIA GeForce 8800M GTX GPU,
while GeForce GTX Titan was used for FLAME GPU immune system ABM [167].
Despite the differences in underlying hardware, MTb ABM simulation is arguably
one of the most suitable works for performance comparison with the 3D VF ABM.
The 2D MTb ABM simulated a complex multi-scale biological system of agents that
communicate via chemical signals, which aligned in most respects with the 3D VF
ABM. The human immune system ABM was built on a widely used HPC ABM
platform, FLAME GPU [167]. Although this ABM executed the immune system
at a much smaller timescale, the cell communication method is similar to other
ABMs included in this performance comparison, i.e. communication via chemical
signals. The FLAME GPU immune system ABM thus served as a good performance
reference.
The 3D VF ABM was simulated at a scale physiologically representative of
a human vocal fold. Such scale was not feasible to be implemented on ABM free-
ware NetLogo [89]. Furthermore, to our best knowledge, no similar scale had been
reported in any other publication. For a common throughput unit, the simulation
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performance was measured in terms of environment space unit per millisecond. The
space units represent the smallest granularity of the ABM environment. Depending
on the model, the space units can be patches [93], grid points [75] or immobile tissue
cells [167]. These quantities determine the ABM environment size. Therefore, the
number of space units are proportional to the amount of work required to simulate
the ABM environment in each iteration. For this reason, space unit per millisecond
serves a reasonable throughput measure. The 3D VF ABM is capable of processing
25K patches/ms, which is about 900x, 63x, 2.3x and 2.4x the throughputs of NetL-
ogo, MTb, FLAME GPU immune system ABM and the 2D VF ABM, respectively.
The comparison of the model scale, complexity and performances are in Table 6.6.
Of note, FLAME GPU can process roughly 1.9x more mobile agents than 3D VF
ABM per time unit. The primary reason was that the time step used in FLAME
GPU immune system ABM are smaller than that of our model in orders of magni-
tudes. This time scale difference caused their agent rules to be much less complex.
For example, FLAME GPU immune system ABM would take roughly 18 hours to
complete a 5-day simulation while the 3D VF ABM only takes less than half an
hour. In addition, the 3D VF ABM offered a much more rigorous data visualization
in real-time at a scale of over 100 times more mobile agents than that of FLAME
GPU immune system ABM.
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Figure 6.7: 3D VF ABM simulation suite performance. Chart demonstrating over-
lapped visualization and computation executions on GPUs and CPUs in terms of
execution time.
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Figure 6.8: Processing power of 3D VF ABM vs. existing work comparison. This
bar chart compares workload and execution time in terms of number of patches (i.e.
lattice points, grid points, stationary cells) per ms between the 3D VF ABM to other
bio-simulation ABM work. Notice that the 3D VF ABM is capable of processing
25K patches/ms, or about 900x, 63x, 2.3x and 2.4x more patch processing power
than NetLogo, MTb ABM [75], FLAME GPU immune system ABM [167] and the
earlier 2D VF ABM work [14].
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2D MTb ABM 16.4 K 3.2 K 1 0 10 min 0.042
2D NetLogo 1.0 M 114.0 K 8 3 30 min 36.6
VF ABM
2D FLAME 320.0 K 160.1 K 1 0 0.2 s 0.03
GPU
2D VF ABM 1.9 M 228.0 K 8 3 30 min 0.19
3D VF ABM 153.8 M 16.9 M 8 3 30 min 6.2
Table 6.6: Performance and scale comparison of 3D VF ABM with existing high-
performance ABM work of similar nature
6.2.3 3D High-Interactivity Human Model
6.2.3.1 Computation-Visualization Performance
As discussed in Section 6.2.2, the original frame rate of the human VF visual-
ization was bounded by the compute time of approximately 7 s per iteration. This
resulted in poor interactivity due to the 0.14 fps frame rate. With the scheduling
technique described Section 3.3, the frame rate improved to 7.2 fps. By using the
subvolume size recommended by the heuristic proposed in Section 5.3.1.2 for HADC
optimization, the visualization performance improved significantly to 42.8 fps.
For performance evaluation purposes, the human VF ABM was compared
against our previous and other similar ABM work (Table 6.7). The bacteria-
macrophage-antibiotic ABM was implemented with FLAME GPU [167]. FLAME
GPU is a widely used modern HPC ABM framework, and thus, serves as a good
performance standard. Additionally, we included a well regarded high-performance
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#Data In Situ Frame Hardware
Points Support Rate
(×106) (fps)










1200 X 0.13 Intel Xeon E5-2699 v4




1700 X 42.8 Intel Xeon E5-2699 v4




Table 6.7: Framerate and scale comparison of 3D VF ABM with existing biological
visualization platforms
visualization prototype, MegaMol for comparison [190]. Despite MegaMol being
an atomic-level visualization prototype, this powerful visualization tool is particle-
based. Since particle-based simulation engine offer frameworks that can be adapted
to visualize cellular-level data, MegaMol is well-suited to serve as our visualization
performance comparison base. Our VF ABM is able to process data orders of mag-
nitude larger than FLAME GPU at a similar frame rate. Furthermore, we are able
to visualize 17x more data points than MegaMol at a 4.2x better frame rate. It is
worth noting that MegaMol does perform more sophisticated rendering process than
our framework. However, while our framework couples the visualization engine with
grid-based real-time data generation, MagaMol did not support this feature [190].
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6.3 Performance-Accuracy Trade-Off Studies
6.3.1 Device-Side Sampling
To understand the trade-offs between speed and accuracy as a result of sam-
pling using GPU texture memory, an experiment using different sampling strides
was performed and the results are shown in Fig. 6.9. The gray area of the plot
in Fig. 6.9(a) represents the cases where chemical data memory requirement is too
large for the GPUs. The performance jumps as we go from the gray area to the white
since sufficient GPU memory means less data movements. The plot in Fig. 6.9(b)
demonstrates the accuracy trade-offs in terms of normalized root-mean-squared er-
ror (NRMSE) that resulted from sampling. The white area of the plot in Fig. 6.9(b)
represents the acceptable range of sampling strides, where the sampling results fit
in the GPU memory and the average accuracy is higher than 95%. Fig. 6.9(c) com-
pares the results of the visualization without sampling and with sampling (6× 6× 6
window). Up to a 63 window, the gradient details are preserved very well. How-
ever, increasing the sampling window size resulted in a noticeable loss of details
visually and numerically (error rising above 5% in Fig. 6.9(b)). Thus, the 63 sam-
pling window was used for the final performance evaluation. Fig. 6.10(a) shows a
comparison of real rat vocal fold images that were obtained experimentally [210] to
a model-generated image. The left most image in Fig. 6.10(a) that was obtained
from an uninjured control rat vocal fold has lower collagen content (red), whereas
the middle image from a scarred vocal fold shows a higher level of collagen content.
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Figure 6.9: A study comparing the performance gain in (a) (frame rate and GPU
memory requirement reduction with solid and dashed lines, respectively) to the
normalized root-mean-squared error (RMSE) shown in (b) with respect to different
sampling window widths. An example of a comparison of the visualization quality
between the original data (left) and sampled data with a 6×6×6 sampling window
(right) is demonstrated in (c). Images of vocal fold tissue in (c) show an early stage
with not much collagen (red) in the wound area (white oval) for a clear view of
chemical (TNF in pink-purple) visualization.
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Figure 6.10: (a) Comparison of vocal fold image (collagen in red, elastin and cells
in green) of real rat vocal fold (uninjured control on the left and scarred in the
middle) [210] and a zoomed image obtained from VF ABM simulation (right). (b)
Visualization of human vocal fold both ECM proteins and signaling proteins (chem-
ical gradients in turquoise-pear) during the healing process. The ECM proteins
include collagen (red), hyaluronic acid (blue), and elastin (green). The healing and
elapsed time stats are displayed in the top-left and top-right corner of the screen,
respectively.
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Figure 6.11: Data transfer time speedup using HADC. For each wound configura-
tion, the model was run with different HADC partition sizes. The partition size that
resulted in the best average data transfer time was used to compute the speedup
(solid blue) and compared with speedup using partition size recommended by heuris-
tic described in Section 5.3.1.2. The 2-pass octree technique (striped) worked well
for small and medium size wounds. In contrary, the scaled 2-pass octree using the
scaled recommendation from smaller wound model, m, for m′ with larger wounds
work well for all wound sizes (dotted).
The rightmost image obtained from a VF ABM simulation of an injured vocal fold
shows a similar collagen content to the scarred vocal fold image. A screenshot of
the in situ visualization of both ECM and signaling proteins, along with healing
and timing stats is shown in Fig. 6.10(b). The visualization of ECM and signal-




To evaluate the quality of the subvolume size recommendation made by the
heuristic proposed in Section 5.3.1.2, an experiment was run with different HADC
partition sizes for different model and wound configurations. The plot in Fig. 6.11
compares best speedup obtained from the experiments with speedup gained us-
ing 2-pass octree and scaled 2-passed octree, respectively. Compared to the best
sub-volume sizes obtained experimentally (brute force), the 2-pass octree technique
performed relatively well for small and medium size wounds (sizes up to 1
3
of the
VF size). However, it did not work well for large wound sizes as it recommended a
sub-optimal partition. Thus, it is best for the modeler to use the discussed scaling
heuristic to obtain the recommendation from smaller wound model, m and scale the
partition size for m′ with larger wounds.
6.4 Model Verification
The trends of the 3D rat and human VF ABM outputs were qualitatively
verified using the pattern-oriented analytical approach [1, 211, 212]. The purpose
of qualitative verification was to ensure that the dynamics of the model reflect




Cell population and ECM protein trends were compared against known pat-
terns reported in wound healing literature as summarized in Table 6.8 [215–224].
Fig. 6.12 shows cellular and molecular outputs of the VF ABM from a 7-day simu-
lation. The model predicted a peak neutrophil population at the end of day 1 and
significant decreases in day 2. The model also reproduced a peak of macrophage
population around day 2 and a downward trend from the beginning of day 3 on-
ward. Furthermore, the fibroblast proliferation started around the end of day one
in the simulation. Trends of these specific cell populations agreed well with the
known patterns in wound healing literature (Table 6.8). For ECM outputs, the VF
ABM reproduced the trends of collagen but not of hyaluronan. In particular, both
empirical and ABM results showed the accumulation of collagen starting from Day
3. The ABM predicted an earlier accumulation of hyaluronan (Day 1) compared
to empirical data (Day 3). This early hyaluronan accumulation might be related
to high levels of TNF-α, TGF-β, FGF and IL-1β that stimulated the secretion of
hyaluronan by fibroblasts in the model. More data and calibration are needed for
further investigation.
6.4.2 Rat Model
Due to the data availability, only a subset of chemicals was compared against
the empirical data [213, 214]. This subset includes measured mRNA levels of three
inflammatory mediators (TNF-α, TGF-β, and IL-1β) out of 8 that are simulated by
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Figure 6.12: Simulation output of 3D human VF ABM for pattern-oriented model




Neutrophils arrive at wound site in first few hours [218–221]
Neutrophil number is at maximum by day 1 or 2 [218–221]
Neutrophil number decreases rapidly around day 3 or 4 [218–221]
Macrophage number is at maximum by days 2 to 4 [218–221]
Fibroblasts start proliferation on day 1 [216]
Fibroblast number decreases significantly on day 7 and stays low [216,218–221]
until day 14
Hyaluronan is first seen on day 3 and peaks at day 5, starts to drop [215,217,222,224]
significantly at day 7, and then remains at low level until day 14
Peak of accumulated hyaluronan content occurs at same time as [222,223]
peak of inflammatory cells (neutrophils and macrophages)
Hyaluronan level is generally lower than for uninjured vocal folds [215,217]
after injury throughout healing period
Collagen type I curve is sigmoid-shaped [220,221]
Collagen type I is first seen on day 3 and peaks on day 5 [215,217]
Collagen type I level is generally higher than for uninjured vocal [215,217]
folds after injury throughout healing period
Table 6.8: Summary of patterns used for qualitative verification of 3D VF ABM [1]
the model. The comparison of the model outputs and the empirical data are shown
in Fig 6.13. The ABM generated a peak of TNF-α after 13 hours (26 ticks) of injury,
whereas this peak occurred at hour 8 (tick 16) in the empirical data. For IL-1β, the
model generated a peak at hour 12 (tick 24), where the peak was observed at hour
8 in the empirical data. Overall, the ABM-predicted peaks for TNF-α and IL-1β
lagged behind the experimentally observed peaks by 4-5 hours. The discrepancy
between the model outputs and literature data may be explained as follows. First,
since TNF-α and IL-1β were down-regulated by TGF-β and IL-10 via macrophages
and fibroblasts, a possible reason for the peak delay could be an insufficient strength
of TGF-β or IL-10. Second, since no empirical data were reported between hour 8
and 16, a peak between this interval might have been missed experimentally. More
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empirical data are needed for further investigation. For TGF, the model missed
predicting the spike at hour 1. However, the sub-linear upward trend from hour
4 till the end of the simulation predicted by the model matched with that of the
empirical data. In sum, the 3D rat VF ABM trajectories of inflammatory mediators
showed a few discrepancies when comparing with the empirical vocal fold data in
literature. Despite these few discrepancies, the overall dynamics of the VF ABM
outputs are consistent with those seen in the empirical data. Note that for this 3D
VF ABM to be clinically ready, more experimental data is needed to calibrate the
model.
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Figure 6.13: Empirical data vs. 3D rat VF ABM simulation output plot. Qualitative
verification of the model output (left) against empirical data [213,214] (right). The
set of verified chemicals includes TNF-α, TGF-β, and IL-1β.
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Chapter 7: Concluding Remarks and Future Perspectives
7.1 Conclusion
In this dissertation, high-performance computing (HPC) techniques for cellular-
level inflammation and repair models were developed to optimize the simulation at
both task-scheduling and task-execution levels. At the task-scheduling level, we
started by building a task categorization method for wound healing applications
that became the basis of our heterogeneous platform task mapping methodology.
This task mapping method was then used in different variations of CPU-GPUs
scheduling schemes to optimally utilize available computing resources on single-
node host-accelerators machine configurations. At the task-execution level, tasks
on CPU underwent further parallelization using OpenMP, while task-specific opti-
mizations and communication reduction techniques were developed for GPU tasks.
Both task-scheduling and task-execution level optimizations were applied first to 2D
models, then more sophisticated optimized variations were applied to 3D models.
Since wound healing models are multi-scale in nature (consisting of molecular
and cellular level operations), the finer scale processes of chemical diffusion were ac-
celerated using FFT-based convolution. The computations of accelerated diffusion
were then assigned to the GPU as these FFT computations involved large amounts
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of data. The cellular-level operations such as cell seeding, cell proliferations and
cell functions were mapped to multi-core CPU and sped up using OpenMP. This
scheduling scheme was applied to 2D vocal fold inflammation and repair model con-
sisting of over 200k biological cells and generated over 20 million data points. The
model computation was then coupled with an advanced visualization component
which displays aggregated statistics and simulation state of multiple components
over spatio-temporal dimensions. To take full advantage of the powerful computa-
tional server, minimize disk load, and enable computational steering, the program
was tested and benchmarked on the system with X11 transport via X proxy protocol
configured. Performance of a 2D simulation of human vocal fold inflammation and
wound healing showed 35x and 7x speedup in execution time over single-core and
multi-core CPU respectively. Each iteration of the model took less than 200 ms to
simulate, visualize and send the results to the client. This enables users to monitor
the simulation in real-time and modify its course as needed.
Next, we transitioned to 3D VF models. Since the 3D human model is sub-
stantially more computationally demanding, we extended the scheduling scheme to
not only overlap fine-grain and coarse-grain computations, but also overlap the visu-
alization operations. The visualization component was optimized with an adaptive
sampling scheme to accelerate the rendering process while maintaining the precision
of the displayed visual results. This visualization optimization ensured that the
execution of the visualization operations is fast enough for the visualization cost
to be completely hidden behind the CPU task execution. This extended schedul-
ing scheme, along with adaptive sampling, resulted in effectively free visualization.
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These techniques, thus, improved the performance of the whole simulation suite
significantly, enabling the simulation and visualization of over 17 million biological
cells and 1.2 billion chemical data points in under 7 seconds per iteration.
Finally, the support for GPU hyper-tasking (GHT) was integrated to our
scheduling scheme. The benefits of GHT are two folds. First, the GPUs responsi-
ble mainly for fine-grain computations can hyper-task between fine-grain computa-
tions and ray-casting (visualization subtask). This allows these non-screen-attached
GPUs to aid in visualizing their local data and minimize peer communications. Sec-
ond, GHT allows the rendering GPU to lighten the computational loads of its peers
by executing leftover fine-grain subtasks, while maintaining high level of visualiza-
tion interactivity. Furthermore, the communications between the CPU host and the
rendering GPU are minimized using an activity-aware data transfer technique to
reduce redundancy in host-device data copies. The combination of GHT scheduling
scheme and redundancy communication reduction allowed for an integration of ad-
ditional 461 million extracellular matrix (ECM) protein data points (on top of 1.23
billion chemical data points) with an increase in visualization interactivity. Our
simulation platform is capable of visualizing these 1.7 billion numerical data points,
as they are being generated (i.e. in-situ visualization), with an average frame-rate
of 42.8 fps. This results in real-time interactivity that allows users explore such
large data sets on a remote server without any lag.
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7.2 Generalization of HPC Techniques
The optimization discussed may seem to be tailored specifically for wound
healing applications. However, chemical diffusion is a crucial part of most models of
biological systems such as hormones in the endocrine system and pharmacokinetics
of drug infusions. In addition, particle diffusion is seen in even larger number of
system modeling applications. Hence, the technique discussed can be applied to a
broad range of system modeling applications involving any type of particle diffusion.
Furthermore, the diffusion equation (Eqn. 4.1) is of the same form as the Heat
Equation, which has an even larger range of applications such as the aforementioned
particle diffusion, Brownian motion [225], Schrodinger equation for a free particle
[226], thermal diffusivity and financial mathematics. And more importantly, if we
generalize the scheduling schemes, the computational overlap techniques can also
be applied to any system modeling application with the following properties:
1. Simulation is carried out in discretized synchronous temporal steps
2. All operations in time step t depend solely on the state of the environment
and agents determined by the end of time step t− 1
3. Computations in each time step can be divided into multiple independent tasks
with at least one task in each of the following categories:
(a) CPU suitable task
(b) Data-intensive GPU suitable task
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(c) Visualization task (optional)
If all the three properties above hold, on of the CPU/GPUs computation over-
lap techniques can be applied to improve efficiency and speed up any system mod-
eling implementation on heterogeneous (CPU/GPU) computing platforms. More
specifically, the scheduling technique discussed in Section 3.2 can be applied to any
application that exhibits all three of the aforementioned properties with low com-
plexity or no visualization tasks. On the other hand, the techniques discussed in
Section 3.3 and 3.4 can be used to improve the performance of applications that ex-
hibit all required properties with high complexity and time consuming visualization
tasks.
7.3 Future Directions
Currently, the cellular level tasks assigned to the CPU are the bottleneck of
the simulation performance. The OpenMP parallelization developed in this work
has likely reached the limit of the utilization of a single multi-core CPU. To fur-
ther enhance the performance, distributed computing need to be considered. There
are a number of existing ABM simulation frameworks that provide parallelization
support on a cluster through MPI [227]. However, none of the existing distributed
ABM frameworks integrated heterogeneous computing techniques to fully utilize
both hosts and accelerators concurrently on all compute nodes. This leaves a win-
dow of opportunity to extend the heterogeneous computing techniques on a single
node described in this dissertation, and provide heterogeneous distributed comput-
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ing support through the combination of OpenMP, CUDA and MPI. In addition to
the MPI support, an adaptation of the HADC technique is also worth explored.
This activity-aware data transfer technique assumed constant subvolume size. An
adaptive version that supports variable subvolume sizes could result in better per-
formance. Since, the HADC technique was designed to minimize host-device com-
munications on a single compute node, further improvements/adaptation have the
potential to increase the efficiency of an MPI implementation by reducing node-node
communications in a distributed computing environment.
The ABM implemented in this work assumed a regular grid simulation envi-
ronment. However, this prevents the modelers from simulating arbitrary, possibly
more realistic, organ shapes. The model implemented in this work used the regular
grid environment to represent a flattened lamina propria section of a vocal fold,
which is soft and pliable tissue. One drawback from this model is the inability
to mimic curvature of the structure present in a real vocal fold, which could have
suppressed the effects the shape has on events like cell migration. Possible ways
to address this limitation is to use indirect addressing to reduce memory footprints
of empty spaces for non-rectangular simulation volume [228], or spatial indices to
represent more realistic 3D volume and efficiently resolve neighbor partitions [229].
At present, cell visualization is supported in our 2D and 3D versions, but
not the high-interactivity 3D version of VF ABM. To integrate cell visualization in
the high-interactivity 3D version, the runtime of cell visualization can be improved
through streaming of cell information (types and locations) from the host to de-
vice. Since the number of cells present in the simulation changes from one iteration
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to another, determining the optimal size of the device-side cell information buffer
can be challenging. A work exploring this idea would, thus, be beneficial to most
large-scale multi-agent applications. Lastly, a systematic way of verifying the visu-
alization outputs through comparison with empirically obtained images can provide
substantial assistance to researchers in testing and refining their models.
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and Diane M Bless. Immediate inflammatory response and scar forma-
tion in wounded vocal folds. Annals of Otology, Rhinology & Laryngology,
115(12):921–929, 2006.
[214] Nathan V Welham, Xinhong Lim, Ichiro Tateya, and Diane M Bless. Inflam-
matory factor profiles one hour following vocal fold injury. The Annals of
otology, rhinology, and laryngology, 117(2):145–152, 2008.
[215] Tomoko Tateya, Jin Ho Sohn, Ichiro Tateya, and Diane M Bless. Histologic
characterization of rat vocal fold scarring. Annals of Otology, Rhinology &
Laryngology, 114(3):183–191, 2005.
[216] Ichiro Tateya, Tomoko Tateya, Xinhong Lim, Jin Ho Sohn, and Diane M
Bless. Cell production in injured vocal folds: a rat study. Annals of Otology,
Rhinology & Laryngology, 115(2):135–143, 2006.
[217] Tomoko Tateya, Ichiro Tateya, Jin Ho Sohn, and Diane M Bless. Histological
study of acute vocal fold injury in a rat model. Annals of Otology, Rhinology
& Laryngology, 115(4):285–292, 2006.
[218] S Cockbill. The healing process. Hospital Pharmasist London, 9(9):255–260,
2002.
[219] Paul Martin. Wound healing–aiming for perfect skin regeneration. Science,
276(5309):75–81, 1997.
[220] Martin C Robson, David L Steed, and Michael G Franz. Wound healing:
biologic features and approaches to maximize healing trajectories. Current
problems in surgery, 38(2):A1–140, 2001.
[221] Maria B Witte and Adrian Barbul. General principles of wound healing.
Surgical Clinics of North America, 77(3):509–528, 1997.
[222] Dianhua Jiang, Jiurong Liang, and Paul W Noble. Hyaluronan in tissue injury
and repair. Annu. Rev. Cell Dev. Biol., 23:435–461, 2007.
[223] Robert Stern, Akira A Asari, and Kazuki N Sugahara. Hyaluronan fragments:
an information-rich system. European journal of cell biology, 85(8):699–715,
2006.
[224] Tracey A Dechert, Ashley E Ducale, Susan I Ward, and Dorne R Yager.
Hyaluronan in human acute and chronic dermal wounds. Wound Repair and
Regeneration, 14(3):252–258, 2006.
[225] George W Bluman. On the transformation of diffusion processes into the
wiener process. SIAM Journal on Applied Mathematics, 39(2):238–247, 1980.
120
[226] James B Anderson. A random-walk simulation of the schrödinger equation:
H+ 3. The Journal of Chemical Physics, 63(4):1499–1503, 1975.
[227] Alban Rousset, Bénédicte Herrmann, Christophe Lang, and Laurent Philippe.
A survey on parallel and distributed multi-agent systems for high performance
computing simulations. Computer Science Review, 22:27–46, 2016.
[228] Amanda Randles, Erik W Draeger, and Peter E Bailey. Massively parallel
simulations of hemodynamics in the primary large arteries of the human vas-
culature. Journal of computational science, 9:70–75, 2015.
[229] AV Husselmann and KA Hawick. Spatial agent-based modelling and
simulations-a review. CSTN Computational Science Technical Note, 153, 2011.
121
